AR - androgen receptor Gene

Also Known as KD; AIS; AR8; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 367

About AR

Cytogenetic location: Xq12 Genomic coordinates (GRCh38): X:67,544,021-67,730,619 (from NCBI)

This gene has 8 transcripts (splice variants), 276 orthologues, 8 paralogues and is associated with 136 phenotypes. Biased expression in liver (RPKM 12.9), endometrium (RPKM 10.8) and 13 other tissues.

Summary

The Androgen Receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]

AR Products (5)

mRNA	Protein	Name
NM_001348063.1	NP_001334992.1	androgen receptor isoform 4
NM_001011645.3	NP_001011645.1	androgen receptor isoform 2
NM_001348064.1	NP_001334993.1	androgen receptor isoform 5
NM_001348061.1	NP_001334990.1	androgen receptor isoform 3
NM_000044.6	NP_000035.2	androgen receptor isoform 1

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	Références	Source
enables ATPase binding	IDA IDA: Inferred from direct assay	12058073	GOA
enables DNA-binding transcription activator activity, RNA polymerase II-specific	IDA IDA: Inferred from direct assay	16728402	GOA
enables DNA-binding transcription factor activity	IDA IDA: Inferred from direct assay	11477070	GOA
enables RNA polymerase II cis-regulatory region sequence-specific DNA binding	IDA IDA: Inferred from direct assay	16728402	GOA
enables RNA polymerase II general transcription initiation factor binding	IPI IPI: Inferred from physical interaction	20181722	GOA
enables RNA polymerase II-specific DNA-binding transcription factor binding	IPI IPI: Inferred from physical interaction	12799378	GOA
enables androgen binding	IDA IDA: Inferred from direct assay	3353726	GOA
enables beta-catenin binding	IDA IDA: Inferred from direct assay	12799378	GOA
enables beta-catenin binding	IPI IPI: Inferred from physical interaction	12799378	GOA
enables chromatin binding	IDA IDA: Inferred from direct assay	21730289	GOA
enables enzyme binding	IPI IPI: Inferred from physical interaction	17277772	GOA
enables molecular adaptor activity	IDA IDA: Inferred from direct assay	11896058	GOA
enables molecular condensate scaffold activity	IDA IDA: Inferred from direct assay	33978290	GOA
NOT enables nuclear receptor activity	IDA IDA: Inferred from direct assay	19244107	GOA
enables nuclear receptor activity	IDA IDA: Inferred from direct assay	12799378	GOA
enables nuclear receptor activity	IMP IMP: Inferred from mutant phenotype	19345326	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	10075738	GOA
enables signaling receptor binding	IPI IPI: Inferred from physical interaction	11875111	GOA
enables transcription cis-regulatory region binding	IDA IDA: Inferred from direct assay	12799378	GOA
enables transcription coactivator binding	IDA IDA: Inferred from direct assay	10428808	GOA
enables transcription coactivator binding	IPI IPI: Inferred from physical interaction	10428808	GOA

Biological Process GO Annotation	Evidence	Références	Source
NOT involved in androgen receptor signaling pathway	IDA IDA: Inferred from direct assay	19244107	GOA
involved in androgen receptor signaling pathway	IDA IDA: Inferred from direct assay	10428808	GOA
involved in cellular response to estrogen stimulus	IDA IDA: Inferred from direct assay	10428808	GOA
involved in cellular response to steroid hormone stimulus	IMP IMP: Inferred from mutant phenotype	12902338	GOA
involved in cellular response to testosterone stimulus	IDA IDA: Inferred from direct assay	10428808	GOA
involved in estrogen receptor signaling pathway	IDA IDA: Inferred from direct assay	10428808	GOA
involved in intracellular receptor signaling pathway	IDA IDA: Inferred from direct assay	17277772	GOA
involved in negative regulation of cell population proliferation	IMP IMP: Inferred from mutant phenotype	14521927	GOA
involved in negative regulation of extrinsic apoptotic signaling pathway	IDA IDA: Inferred from direct assay	21310825	GOA
involved in negative regulation of integrin biosynthetic process	IDA IDA: Inferred from direct assay	21310825	GOA
involved in negative regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	12902338	GOA
involved in non-membrane-bounded organelle assembly	IDA IDA: Inferred from direct assay	36229685	GOA
involved in positive regulation of DNA-templated transcription	IDA IDA: Inferred from direct assay	11477070	GOA
involved in positive regulation of NF-kappaB transcription factor activity	IMP IMP: Inferred from mutant phenotype	21310825	GOA
involved in positive regulation of cell differentiation	IMP IMP: Inferred from mutant phenotype	14521927	GOA
involved in positive regulation of cell population proliferation	IDA IDA: Inferred from direct assay	17277772	GOA
involved in positive regulation of gene expression	IDA IDA: Inferred from direct assay	24681825	GOA
involved in positive regulation of gene expression	IMP IMP: Inferred from mutant phenotype	14521927	GOA
involved in positive regulation of integrin biosynthetic process	IDA IDA: Inferred from direct assay	21310825	GOA
involved in positive regulation of miRNA transcription	IDA IDA: Inferred from direct assay	25802280	GOA
involved in positive regulation of phosphorylation	IMP IMP: Inferred from mutant phenotype	21310825	GOA
involved in positive regulation of transcription by RNA polymerase II	IDA IDA: Inferred from direct assay	12799378	GOA
involved in positive regulation of transcription by RNA polymerase II	IMP IMP: Inferred from mutant phenotype	19244107	GOA
involved in positive regulation of transcription by RNA polymerase III	IDA IDA: Inferred from direct assay	18487222	GOA
involved in regulation of protein localization to plasma membrane	IDA IDA: Inferred from direct assay	21310825	GOA

Cellular Component GO Annotation	Evidence	Références	Source
located in chromatin	IDA IDA: Inferred from direct assay	17277772	GOA
located in cytoplasm	IDA IDA: Inferred from direct assay	15572661	GOA
located in nuclear speck	IDA IDA: Inferred from direct assay	23566155	GOA
located in nucleus	IDA IDA: Inferred from direct assay	15572661	GOA
is active in plasma membrane	IMP IMP: Inferred from mutant phenotype	22031296	GOA
part of protein-containing complex	IDA IDA: Inferred from direct assay	18468998	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

AR Protein Structure

Androgen_recep

zf-C4

Hormone_recep

0
200
400
600
800
920 a.a.

Protein Preferred Names	Protein Names
androgen receptor	dihydrotestosterone receptor nuclear receptor subfamily 3 group C member 4

AR Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	Références
Intra	AR	P10275	BTG2	Homo sapiens	P78543	Pull Down	21172304
Intra	AR	P10275	PARK7	Homo sapiens	Q99497	Anti Bait CoIP	17510388
Intra	AR	P10275	PARK7	Homo sapiens	Q99497	Y2H	17510388
Intra	AR	P10275	PARK7	Homo sapiens	Q99497	Confocal	17510388
Intra	AR	P10275	JMJD1C	Homo sapiens	Q15652	BioID	33640491
Intra	AR	P10275	KDM5D	Homo sapiens	Q9BY66-3	Anti Tag CoIP	27185910
Cross	AR	P10275	Foxo1	Mus musculus	Q9R1E0	Y2H	17202144
Cross	AR	P10275	Foxo1	Mus musculus	Q9R1E0	Anti Bait CoIP	17202144
Cross	AR	P10275	Foxo1	Mus musculus	Q9R1E0	Confocal	17202144
Intra	AR	P10275	SMAD1	Homo sapiens	Q15797	Anti Bait CoIP	17183365
Intra	AR	P10275	DDC	Homo sapiens	P20711	Anti Bait CoIP	12864730
Intra	AR	P10275	DDC	Homo sapiens	P20711	Reverse Y2H	12864730
Intra	AR	P10275	FOXH1	Homo sapiens	O75593	Gal4 VP16 Complement	16120611
Intra	AR	P10275	RNF6	Homo sapiens	Q9Y252	Anti Bait CoIP	19345326
Intra	AR	P10275	NSD2	Homo sapiens	O96028	Anti Tag CoIP	19481544
Intra	AR	P10275	NSD2	Homo sapiens	O96028	IF	19481544
Intra	AR	P10275	IFI16	Homo sapiens	Q16666	Anti Bait CoIP	16494870
Intra	AR	P10275	GSN	Homo sapiens	P06396	Y2H	19574450
Intra	AR	P10275	GSN	Homo sapiens	P06396	T7 Phage	19574450
Intra	AR	P10275	PRDX1	Homo sapiens	Q06830	Anti Bait CoIP	17909037
Intra	AR	P10275	PRDX1	Homo sapiens	Q06830	Pull Down	17909037
Intra	AR	P10275	CCND1	Homo sapiens	P24385	Anti Bait CoIP	16461912
Intra	AR	P10275	MDM2	Homo sapiens	Q00987	Anti Bait CoIP	18332867
Intra	AR	P10275	MAK	Homo sapiens	P20794	Anti Tag CoIP	16951154
Intra	AR	P10275	MAK	Homo sapiens	P20794	Anti Bait CoIP	16951154
Intra	AR	P10275	FOXA1	Homo sapiens	P55317	Anti Bait CoIP	23260764
Intra	AR	P10275	FOXA1	Homo sapiens	P55317	BioID	33640491
Intra	AR	P10275	FOXA1	Homo sapiens	P55317	Anti Bait CoIP	22722839
Intra	AR	P10275	HIF1A	Homo sapiens	Q16665	Anti Bait CoIP	17426252
Intra	AR	P10275	KAT7	Homo sapiens	O95251	Pull Down	10930412
Intra	AR	P10275	CTNNB1	Homo sapiens	P35222	Anti Bait CoIP	21885566
Intra	AR	P10275	CTNNB1	Homo sapiens	P35222	Anti Bait CoIP	10987273
Intra	AR	P10275	CTNNB1	Homo sapiens	P35222	Pull Down	12588987
Intra	AR	P10275	CTNNB1	Homo sapiens	P35222	Confocal	21741601
Intra	AR	P10275	CTNNB1	Homo sapiens	P35222	Anti Bait CoIP	12588987
Intra	AR	P10275	ASH2L	Homo sapiens	Q9UBL3	BioID	33640491
Intra	AR	P10275	ASH2L	Homo sapiens	Q9UBL3	Anti Bait CoIP	22722839
Intra	AR	P10275	KMT2A	Homo sapiens	Q03164	Anti Bait CoIP	22722839
Intra	AR	P10275	KMT2A	Homo sapiens	Q03164	Anti Tag CoIP	33640491
Intra	AR	P10275	KMT2A	Homo sapiens	Q03164	BioID	33640491
Intra	AR	P10275	DAXX	Homo sapiens	Q9UER7	Anti Tag CoIP	15572661
Intra	AR	P10275	DAXX	Homo sapiens	Q9UER7	Pull Down	15572661
Intra	AR	P10275	CASP8	Homo sapiens	Q14790	Pull Down	17170703
Intra	AR	P10275	NCOA6	Homo sapiens	Q14686	BioID	33640491
Intra	AR	P10275	ERG	Homo sapiens	P11308	Anti Bait CoIP	22531786
Intra	AR	P10275	ERG	Homo sapiens	P11308	Anti Bait CoIP	22722839
Intra	AR	P10275	SUMO1	Homo sapiens	P63165	Enzymatic Study	21242980
Intra	AR	P10275	SUMO1	Homo sapiens	P63165	Anti Bait CoIP	21242980
Intra	AR	P10275	CREBBP	Homo sapiens	Q92793	Anti Bait CoIP	20541699
Intra	AR	P10275	CREBBP	Homo sapiens	Q92793	BioID	33640491
Intra	AR	P10275	NCOA2	Homo sapiens	Q15596	BioID	33640491
Intra	AR	P10275	NCOA2	Homo sapiens	Q15596	Anti Bait CoIP	12588987
Intra	AR	P10275	NCOA2	Homo sapiens	Q15596	X-Ray Diffraction	15563469
Intra	AR	P10275	BRD4	Homo sapiens	O60885-1	Anti Bait CoIP	24759320
Intra	AR	P10275	BRD4	Homo sapiens	O60885-1	GMS	24759320
Intra	AR	P10275	BRD4	Homo sapiens	O60885-1	Anti Tag CoIP	24759320
Intra	AR	P10275	BRD4	Homo sapiens	O60885-1	BLI	24759320
Cross	AR	P10275	Siah2	Mus musculus	Q06986	Pull Down	23518348
Cross	AR	P10275	Siah2	Mus musculus	Q06986	Anti Tag CoIP	23518348
Intra	AR	P10275	KMT2D	Homo sapiens	O14686	Anti Bait CoIP	22722839
Intra	AR	P10275	KMT2D	Homo sapiens	O14686	BioID	33640491

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant AR Proteins

Cat. No.	Nom du produit	Accession	Pureté
HY-P72088	Androgen receptor Protein, Human (His-SUMO, Myc)	P10275-1 (D551-T919)	≥ 90%, as determined by reducing SDS-PAGE.

AR Anticorps

Cat. No.	Nom du produit	Application	Reactivity
HY-P80014	Androgen receptor Antibody (YA620)	WB	Human
HY-P86132	Androgen Receptor Antibody (YA5824)	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat

Related Diseases

Diseases	Alias
Varicocele	Scrotal Varices Varicoceles Varicocele Of Scrotum Scrotal Varicocele
Amelogenesis Imperfecta	Ai Congenital Enamel Hypoplasia Al - [Amelogenesis Imperfecta]
Autism	Autistic Disorder Autism Susceptibility 1 Childhood Autism Autistic Disorder Of Childhood Onset Infantile Autism Kanner'S Syndrome Autistic
Autosomal Dominant Cerebellar Ataxia	Spinocerebellar Ataxia Adca Pierre Marie Cerebellar Ataxia Ataxia, Spinocerebellar Sca Autosomal Dominant Spinocerebellar Ataxia Spinocerebellar Ataxias
Spinal Muscular Atrophy	Sma 5q Sma Proximal Sma Sma-Associated Sma Spinal Amyotrophies Spinal Amyotrophy Spinal Muscle Degeneration Spinal Muscle Wasting Muscular Atrophy Spinal Atrophy, Muscular, Spinal Hereditary Motor Neuronopathy Progressive Muscular Atrophy Sma - [Spinal Muscular Atrophy]
Pre-Eclampsia	Preeclampsia Gestational Hypertension Hypertension Induced By Pregnancy Pre-Eclamptic Toxaemia Pregnancy Associated Hypertension Proteinuric Hypertension Of Pregnancy Hypertension, Pregnancy-Induced, Susceptibility To Preeclampsia/Eclampsia Pregnancy Toxemia Toxaemia Of Pregnancy Gestational Proteinuric Hypertension Pregnancy-Induced Hypertension Toxemia Of Pregnancy Preeclampsia, Susceptibility To Transient Hypertension Of Pregnancy Gestational [Pregnancy-Induced] Hypertension Without Significant Proteinuria Gestational Hypertension Nos Mild Proteinuric Hypertension Of Pregnancy Pih - [Pregnancy-Induced Hypertension] Pregnancy-Induced Hypertension Nos Gestational [Pregnancy-Induced] Hypertension With Significant Proteinuria Pe - [Pre-Eclampsia] Pre-Eclampsia Nos Pre-Eclamptic Nos Pregnancy Pre-Eclampsia Puerperal Pre-Eclampsia Pre-Eclampsia Toxaemia Toxaemia In Pregnancy Pet - [Pre-Eclamptic Toxaemia] Maternal Toxaemia
Female Breast Cancer	Female Breast Carcinoma Carcinoma Of Female Breast Mammary Carcinoma Of Female Breast Malignant Neoplasm Of Female Breast
Vulvar Sebaceous Carcinoma
Breast Cancer	Breast Carcinoma Breast Cancer, Familial Malignant Neoplasm Of Breast Male Breast Cancer Breast Cancer, Susceptibility To Breast Cancer, Early-Onset Malignant Tumor Of Breast Carcinoma Of Male Breast Breast Cancer, Invasive Ductal Breast Cancer, Protection Against Breast Cancer, Somatic Breast Cancer, Male Breast Cancer, Lobular, Somatic Breast Tumor Mammary Cancer Mammary Tumor Malignant Neoplasm Of Male Breast Mammary Carcinoma Male Breast Carcinoma Familial Cancer Of Breast Invasive Ductal Breast Carcinoma Breast Cancer Susceptibility Breast Cancer, Male, Susceptibility To Breast Cancer, Early-Onset, Susceptibility To Malignant Tumor Of The Breast Mammary Neoplasm Primary Breast Cancer Neoplasm Of Male Breast Carcinoma Of Breast Breast Cancer In Men Familial Breast Cancer Cancer Of Breast BC Breast Cancer Familial Breast Cancer Familial Male Breast Cancer, Familial Male Breast Male Carcinoma Breast Neoplasms Breast Neoplasms, Male Mammary Tumors Mammary Carcinomas Cancer, Breast Cancer, Breast, Susceptibility Invasive Breast Ductal Carcinoma Breast Neoplasm Susceptibility To Breast Cancer Mammary Neoplasms Animal Mammary Neoplasms Primary Malignant Neoplasm Of Breast Infiltrating Ductal Carcinoma Of Breast Infiltrating Duct Carcinoma Of Unspecified Site Infiltrating Ductular Carcinoma Of Unspecified Site Invasive Breast Carcinoma Of No Special Type Microinvasive Carcinoma Of Breast Carcinoma With Apocrine Differentiation
Withdrawal Disorder	Withdrawal Syndrome Substance Withdrawal Syndrome
X-Linked Monogenic Disease
Neurofibroma	Neurofibromas Neurofibromatoses Nerve Sheath Tumors
Machado-Joseph Disease	SCA3 MJD Spinocerebellar Ataxia 3 Azorean Disease Spinocerebellar Ataxia Type 3 Azorean Neurologic Disease Spinopontine Atrophy Nigrospinodentatal Degeneration Spinocerebellar Atrophy Spinocerebellar Atrophy Iii Spinocerebellar Atrophy Type 3 Azorean Ataxia Azorean Disease Of The Nervous System Machado Disease Nigro-Spino-Dentatal Degeneration With Nuclear Ophthalmoplegia Disease, Machado-Joseph Ataxia, Spinocerebellar
Teeth Hard Tissue Disease
Breast Fibroadenoma	Fibroadenoma Fibroadenoma Of Breast Juvenile Fibroadenoma Of Breast Cellular Fibroadenoma Complex Fibroadenoma Of Breast Juvenile Fibroadenoma Fibroadenoma Nos Fibroadenoma Unspecified Site
Hyperandrogenism	Hyperandrogenization Syndrome
Nervous System Disease	Abnormality Of The Nervous System Nervous System Diseases Nervous System Disorder
Disorder Of Sexual Development	Disorder Of Sex Development Sex Development Disorder Sex Differentiation Disease Dsd Disorders Of Sex Development Sex Differentiation Disorders
Premature Menopause	Primary Ovarian Insufficiency Premature Ovarian Failure Hypergonadotropic Hypogonadism Premature Ovarian Insufficiency Menopause - Premature Menopause Praecox Menopause Premature Menopause, Premature Female Hypergonadotropic Hypogonadism Hypergonadotrophic Ovarian Failure Primary Female Hypogonadism Pof - [Premature Ovarian Failure] Ovarian Failure Ovarian Secretion Suppression Ovary Hyposecretion Ovary Secretion Deficiency Premature Menopause Nos
Ductal Carcinoma In Situ	Noninfiltrating Intraductal Carcinoma
Prostate Cancer	Prostate Carcinoma Prostate Cancer, Familial Prostate Neoplasm Prostate Cancer, Somatic Prostate Cancer, Susceptibility To Prostatic Cancer Prostatic Neoplasms Hereditary Prostate Cancer Prostatic Neoplasm Cancer Of Prostate Carcinoma Of Prostate Familial Prostate Cancer Familial Prostate Carcinoma Malignant Tumor Of Prostate Malignant Neoplasm Of Prostate Prostate Cancer, Familial, Susceptibility To Malignant Tumor Of The Prostate Ngp - New Growth Of Prostate Tumor Of The Prostate Prostate Cancer, Hereditary Cancer Of The Prostate Malignant Neoplasm Of The Prostate Prostatic Carcinoma PC Prca Cancer, Prostate Malignant Prostatic Tumour Malignant Tumour Of Prostate Primary Prostate Cancer Primary Malignant Neoplasm Of Prostate Prostate Gland Cancer
Breast Ductal Carcinoma	Ductal Breast Carcinoma Duct Carcinoma Carcinoma, Ductal Mammary Ductal Carcinoma Ductal Carcinoma
Alopecia
Ovarian Cancer	Ovarian Carcinoma Ovarian Neoplasm Malignant Tumour Of Ovary Epithelial Ovarian Cancer Neoplasm Of Ovary Ovarian Neoplasms Ovarian Cancers Malignant Neoplasm Of Ovary Primary Malignant Neoplasm Of Ovary Ovarian Cancer, Somatic Malignant Ovarian Tumor Ovary Neoplasm Primary Ovarian Cancer Tumor Of The Ovary Cancer Of The Ovary Malignant Neoplasm Of The Ovary Malignant Tumor Of The Ovary Ovarian Malignant Tumor OC Ovarian Carcinomas Cancer, Ovarian Cancer Of Ovary Ovary Cancer Ca Ovary
Oligospermia
Germ Cell Cancer	Malignant Germ Cell Tumor Germ Cell Neoplasm Germ Cell Tumour Malignant Tumor Of The Germ Cell Neoplasms Germ Cell Neoplasms, Germ Cell And Embryonal Malignant Germ Cell Neoplasm
Androgen Insensitivity Syndrome	Androgen Resistance Syndrome AIS Testicular Feminization Syndrome Androgen Receptor Deficiency Dihydrotestosterone Receptor Deficiency Dhtr Deficiency Ar Deficiency Testicular Feminization Tfm Androgen Insensitivity Androgen-Insensitivity Syndrome Goldberg-Maxwell Syndrome Complete Androgen Insensitivity Syndrome Cais Feminisation - Testicular Goldberg - Maxwell Syndrome Androgen Insensitivity Syndrome, Complete Morris Syndrome Ary AR Insensitivity Syndrome, Androgen Androgen Insensitivity Nos
Premature Ejaculation
Breast Lobular Carcinoma	Cancer, Breast, Lobular Lobular Breast Carcinoma
Prostate Small Cell Carcinoma	Small Cell Carcinoma Of Prostate Prostate Oat Cell Carcinoma
Endometrial Cancer	Endometrial Carcinoma Endometrial Neoplasm Malignant Neoplasm Of Endometrium Endometrioid Carcinoma Endometrial Neoplasms Carcinoma, Endometrioid Endometrial Cancer, Familial Endometrial Carcinoma, Somatic Endometrial Cancer, Susceptibility To Endometrial Ca Malignant Endometrial Neoplasm Neoplasm Of Endometrium Primary Malignant Neoplasm Of Endometrium Tumor Of Endometrium Carcinoma Of The Endometrium Endometrioid Carcinoma Of Female Reproductive System ENDMC Carcinoma Endometrioid Endometrial Cancers Cancer, Endometrial Uterine Corpus Cancer
Prostate Carcinoma In Situ	Carcinoma In Situ Of Prostate Grade Iii Pin Pin Iii
Prostatitis
Polycystic Ovary Syndrome	Polycystic Ovarian Syndrome Pcos Polycystic Ovaries Stein-Leventhal Syndrome Multicystic Ovaries Polycystic Ovarian Disease Polycystic Ovary Sclerocystic Ovaries Sclerocystic Ovary Syndrome Stein-Leventhal Synd. Cystic Disease Of Ovaries Cystic Disease Of Ovary Pco Pcod Sclerocystic Ovarian Degeneration Polycystic Ovary Syndrome, Susceptibility To Pcos - [Polycystic Ovary Syndrome] Polycystic Ovary Nos Pco - [Polycystic Ovary]
Sweat Gland Cancer	Sweat Gland Carcinoma Malignant Neoplasm Of Sweat Gland Malignant Tumor Of The Sweat Gland Carcinoma Of The Sweat Gland Primary Malignant Neoplasm Of Sweat Gland Sweat Gland Neoplasms
Spinocerebellar Ataxia 1	Spinocerebellar Ataxia Type 1 SCA1 Olivopontocerebellar Atrophy I Opca1 Opca4 Menzel Type Opca Schut-Haymaker Type Opca Spinocerebellar Atrophy I Opca I Olivopontocerebellar Atrophy Iv Opca Iv Cerebelloparenchymal Disorder I Cpd1 Olivopontocerebellar Atrophy 1 Cerebelloparenchymal Disorder 1 Olivopontocerebellar Atrophy 4 Spinocerebellar Atrophy 1 Type 1 Spinocerebellar Ataxia Spinocerebellar Ataxia-1 Ataxia, Spinocerebellar, Type 1
Cryptorchidism, Unilateral Or Bilateral	Cryptorchidism Undescended Testicle Undescended Testis Cryptorchism Undescended Testicles CRYPTO Impaired Testicular Descent Cryptosporidiosis Retained Testis Unilateral Cryptorchidism Unilateral Undescended Testis Nondescent Unilateral Testicle Unilateral Cryptorchism Ectopic Testis, Unilateral Bilateral Cryptorchidism Bilateral Cryptorchism Bilateral Nondescent Testicle Bilateral Undescended Testes Bilateral Ectopic Testes
Male Reproductive System Disease	Genital Diseases, Male Disorder Of Male Reproductive System
Angelman Syndrome	AS Happy Puppet Syndrome Happy Puppet Syndrome, Formerly Puppetlike Syndrome
Non-Syndromic X-Linked Intellectual Disability 19	Mrx19
Diabetes Mellitus	Diabetes
Prostatic Hyperplasia, Benign	Benign Prostatic Hyperplasia BPH Prostatic Hyperplasia
Androgen Insensitivity, Partial	Partial Androgen Insensitivity Syndrome Reifenstein Syndrome PAIS Androgen Insensitivity, Partial, With Or Without Breast Cancer Familial Incomplete Male Pseudohermaphroditism, Type 1 Androgen Insensitivity Syndrome, Partial Androgen Resistance Syndrome, Partial Reifenstein Syndrome, Partial Partial Androgen Resistance Syndrome Androgen Insensitivity Partial With Or Without Breast Cancer Androgen Insensitivity Syndrome Partial Insensitivity Syndrome, Androgen, Partial, With/Without Breast Cancer Syndrome
Infertility
Prostatic Hypertrophy	Benign Prostatic Hypertrophy Prostatic Hyperplasia
Neuromuscular Disease	Neuromuscular Diseases Neuromuscular Disorders Neuromuscular Disorder
Lacrimal Gland Squamous Cell Carcinoma	Epidermoid Carcinoma Of The Lacrimal Gland Squamous Cell Carcinoma Of Lacrimal Gland
Colorectal Cancer	Colon Cancer Colorectal Carcinoma Colon Carcinoma Colorectal Cancer, Susceptibility To Carcinoma Of Colon CRC Colorectal Cancer With Chromosomal Instability, Somatic Colon Cancer, Somatic Colon Cancer, Susceptibility To Colonic Neoplasms Colorectal Neoplasms Colorectal Cancer, Somatic Colon Cancer, Advanced, Somatic Colonic Carcinoma Colorectal Carcinomas Colon Cancers Colorectal Cancers Cancer, Colorectal, Somatic Cancer, Colon Cancer, Colorectal, Susceptibility To Colorectal Neoplasm Colonic Neoplasm Malignant Tumor Of Colon
Apocrine Adenocarcinoma	Apocrine Carcinoma Apocrine Gland Carcinoma Carcinoma Of The Apocrine Gland Carcinoma Of Apocrine Gland
Gynecomastia
Peripheral Nervous System Disease	Peripheral Neuropathy Peripheral Nerve Disease Peripheral Nerve Disorders Neuropathy, Peripheral Peripheral Neuropathy Due To Vitamin Pyridoxine Hyperalimentation
Microphthalmia, Syndromic 13	X-Linked Colobomatous Microphthalmia-Microcephaly-Intellectual Disability-Short Stature Syndrome MCOPS13 Maine Microphthalmos Colobomatous Microphthalmia With Microcephaly, Short Stature, And Psychomotor Retardation Syndromic Microphthalmia 13 X-Linked Colobomatous Microphthalmia-Microcephaly-Short Stature-Psychomotor Retardation Syndrome Microphthalmia, Syndromic, 13 Microphthalmia, Syndromic, Type 13
Prostate Calculus	Calculus Of Prostate Prostatic Lithiasis Stone Of Prostate Prostatic Stone Prostate Calculi Prostatolithiasis
Acne	Acne Vulgaris Acne Varioliformis Frontalis Acne
Inguinal Hernia	Hernia Inguinal Hernia, Inguinal Inguinal Hernias Bubonocele Indirect Inguinal Hernia Direct Inguinal Hernia Oblique Inguinal Hernia Scrotal Hernia Ih - [Inguinal Hernia]
Suppression Of Tumorigenicity 12	Prostate Adenocarcinoma Adenocarcinoma Of Prostate ST12 Prostate Adenocarcinoma 1 Pac1
Prader-Willi Syndrome	Prader-Labhart-Willi Syndrome PWS Willi-Prader Syndrome Prader-Willi Syndrome Due To Translocation Prader-Willi Syndrome Due To Maternal Uniparental Disomy Of Chromosome 15 Prader Willi Syndrome Prader-Willi Syndrome Due To Imprinting Mutation Upd(15)Mat
Testicular Germ Cell Cancer	Germ Cell Tumor Of Testis Testicular Germ Cell Tumor Testicular Germ Cell Neoplasm Testicular Malignant Germ Cell Tumor
Asthma	Chronic Obstructive Asthma Asthma, Diminished Response To Antileukotriene Treatment In Bronchial Hyperreactivity Asthma, Susceptibility To Asthma, Bronchial Asthma, Protection Against Asthma, Nocturnal, Susceptibility To Nocturnal Asthma Asthma-Related Traits Asthma-Related Traits, Susceptibility To Asthma, Nocturnal Chronic Obstructive Asthma With Acute Exacerbation Chronic Obstructive Asthma With Status Asthmaticus Exercise Induced Asthma Exercise-Induced Asthma Bronchial Asthma Asthma, Exercise-Induced Idiosyncratic Asthma Unspecified Asthma With Acute Exacerbation Asthma, Unspecified, With Stated Status Asthmaticus Status Asthmaticus Nos Acute Severe Asthma Acute Severe Bronchial Asthma Status Asthma Status Post Asthmaticus
Male Reproductive Organ Cancer	Genital Neoplasms, Male Male Genital Cancer Male Genital Neoplasm Male Reproductive System Neoplasm Malignant Neoplasm Of Male Genital Organ Malignant Neoplasm Of Male Genital Organ Or Tract Malignant Neoplasm Of Male Genital Organs Malignant Tumor Of Male Genital Organ Malignant Tumor Of Male Reproductive System Neoplasm Of Male Genital Organ Tumor Of Male Reproductive System
Pseudohermaphroditism	Indeterminate Sex And Pseudohermaphroditism
Adenosquamous Breast Carcinoma
Androgenic Alopecia	Androgenetic Alopecia Alopecia Androgenetica, Male Pattern Baldness
Spinal Disease	Spinal Disorder Spinal Diseases
Hair Disease	Hair Diseases Hair Anomaly Hair Disorder Hair Problems
Motor Neuron Disease	Anterior Horn Cell Disease Motor Neuron Diseases Mnd - [Motor Neurone Disease] Lou Gehrig Disease Creeping Palsy Creeping Paralysis Bulbar Motor Neuron Disease Bulbar Syndrome Anterior Horn Cell Disorder Hereditary Motor Neuron Disease
Hypospadias	Hypospadias Familial Familial Hypospadias
Penis Agenesis	Micropenis Agenesis Of The Penis Penis Agenesia
Apocrine Sweat Gland Neoplasm	Apocrine Tumor Apocrine Neoplasm
Impotence	Erectile Dysfunction Sexual Impotence Erectile Dysfunction Adverse Event
Retinitis Pigmentosa	RP Rod-Cone Dystrophy Autosomal Recessive Retinitis Pigmentosa Non-Syndromic Retinitis Pigmentosa Pericentral Pigmentary Retinopathy Pigmentary Retinopathy Tapetoretinal Degeneration Rcd Retinitis Pigmentosa Autosomal Recessive ARRP Retinitis Pigmentosa, Autosomal Recessive Retinitis Pigmentosa 1
X-Linked Recessive Disease
17-Beta Hydroxysteroid Dehydrogenase Iii Deficiency	17-Ksr Deficiency Neutral 17-Beta-Hydroxysteroid Oxidoreductase Deficiency Pseudohermaphroditism, Male, With Gynecomastia 17-Beta Hydroxysteroid Dehydrogenase 3 Deficiency Testosterone 17-Beta-Dehydrogenase Deficiency 17-Ketosteroid Reductase Deficiency Of Testis 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency 17-Ketoreductase Deficiency 17-Ketosteroidreductase Deficiency 46,Xy Disorder Of Sex Development Due To 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency Male Pseudohermaphroditism With Gynecomastia 17 Alpha Ksr Deficiency 17 Alpha Ketosteroid Reductase Deficiency Of Testis 17 Beta Hydroxysteroid Dehydrogenase Iii Deficiency Male Pseudoherma-Phroditism With Gynecomastia Neutral 17 Beta Hydroxysteroid Oxidoreductase Deficiency Male Pseudohermaphrodism With Gynecomastia MPH 17-Hydroxysteroid Dehydrogenase Deficiency
Testicular Disease	Testicular Dysfunction Testicular Diseases Disorder Of Testis Testis Disorder Testicular Disorders
Autism Spectrum Disorder	Asd Autism Spectrum Disorders Autistic Continuum Pervasive Developmental Disorder Pervasive Development Disorder Autistic Behavior Autistic Disorder Autistic Autistic Disorder Of Childhood Onset Infantile Autism Childhood Autism Kanner Syndrome Pervasive Developmental Delay Nos Pervasive Developmental Disorder, Not Otherwise Specified
Vaginitis	Infective Vaginitis Inflammation Of Vagina Colpitis Vaginal Inflammation Vaginitis Nos
Male Infertility	Infertility, Male Infertility Male Male Sterility Absolute Infertility
Sebaceous Adenocarcinoma	Sebaceous Carcinoma Adenocarcinoma Of The Sebaceous Gland Malignant Neoplasm Of Sebaceous Gland Malignant Sebaceous Tumor Adenocarcinoma, Sebaceous Malignant Sebaceous Neoplasm Sebaceous Gland Neoplasms
Endometrial Hyperplasia
Sexual Health Disorder	Sexual Health
Combined Immunodeficiency	Combined T Cell And B Cell Immunodeficiency Congenital Combined Immunodeficiency Syndrome With Combined Immunodeficiency Combined T And B Cell Immunodeficiency Combined Immunity Deficiency Combined Immunodeficiency Syndrome Combined T-Cell And B-Cell Immunodeficiency Lymphopenic Agammaglobulinaemia
Spermatogenic Failure 4	Spermatogenesis Arrest SPGF4 Azoospermia Due To Perturbations Of Meiosis Azoospermia With Maturation Arrest Pregnancy Loss, Recurrent, 4 Arrest Of Spermatogenesis RPRGL4 Recurrent Pregnancy Loss 4
Spinal And Bulbar Muscular Atrophy, X-Linked 1	Kennedy Disease Sbma Spinal And Bulbar Muscular Atrophy Kennedy'S Disease X-Linked Spinal And Bulbar Muscular Atrophy SMAX1 Kd Kennedy Spinal And Bulbar Muscular Atrophy Spinobulbar Muscular Atrophy Bulbospinal Muscular Atrophy, X-Linked Bulbospinal Neuronopathy, X-Linked Recessive Xbsn Spinal And Bulbar Muscular Atrophy Of Kennedy Bulbospinal Muscular Atrophy X-Linked Bulbospinal Amyotrophy Bulbo-Spinal Atrophy, X-Linked Spinal Bulbar Muscular Atrophy X-Linked Bulbo-Spinal Atrophy X-Linked Spinal Bulbar Muscular Atrophy X-Linked Bsma X-Linked Bulbospinal Muscular Atrophy Spinal And Bulbar Muscular Atrophy X-Linked 1 Bulbospinal Muscular Atrophy X-Linked Bulbospinal Neuronopathy X-Linked Recessive Kennedy Disease) Kennedy Syndrome Atrophy, Muscular, Spinal And Bulbar, Kennedy Type Atrophy, Muscular, Spinobulbar Bulbospinal Neuronopathy
Hypogonadism
Aromatase Excess Syndrome	AEXS Increased Aromatase Activity Familial Hyperestrogenism Hereditary Prepubertal Gynecomastia Aromatase Activity, Increased Familial Gynecomastia Due To Increased Aromatase Activity Hereditary Gynecomastia Gynecomastia, Familial Familial Gynecomastia
46,Xy Sex Reversal 9	SRXY9 46,Xy Sex Reversal, Zfpm2-Related 46xy Sex Reversal 9
Alopecia, Androgenetic, 1	Androgenetic Alopecia Androgenic Alopecia AGA1 Aga Female Pattern Baldness Male Pattern Alopecia Male Pattern Baldness Pattern Baldness Alopecia, Androgenetic Alopecia Androgenetic Female Pattern Alopecia
Dentatorubral-Pallidoluysian Atrophy	DRPLA Naito-Oyanagi Disease Haw River Syndrome Myoclonic Epilepsy With Choreoathetosis Nod Ataxia, Chorea, Seizures, And Dementia Dentatorubropallidoluysian Atrophy Hrs Naito Oyanagi Disease Dentatorubral Pallidoluysian Atrophy Dentatorubro-Pallidoluysian Atrophy Myoclonic Epilepsies, Progressive Atrophy, Pallidoluysian, Dentatorubral
Muscular Atrophy	Muscle Wasting Amyotrophia Wasting - Muscle Skeletal Muscle Atrophy
Asperger Syndrome	Asperger Disorder
Ovarian Disease	Ovarian Dysfunction Ovarian Diseases Ovarian Disorders Disorder Of Endocrine Ovary
Male Reproductive Organ Benign Neoplasm
Eyelid Carcinoma	Carcinoma Of The Eyelid
Salivary Gland Disease	Salivary Gland Disorders Salivary Gland Diseases Non-Neoplastic Salivary Gland Disease Non-Neoplastic Salivary Gland Disorder Disorder Of Salivary Gland Lesion Of Salivary Gland Nos
Myopathy	Muscular Diseases Myopathies
Lipoid Congenital Adrenal Hyperplasia	Congenital Adrenal Hyperplasia Congenital Lipoid Adrenal Hyperplasia Due To Star Deficency Congenital Lipoid Adrenal Hyperplasia Lipoid Cah Lipoid Adrenal Hyperplasia Adrenal Hyperplasia 1 Cah Clah LCAH Adrenal Hyperplasia I Lipoid Hyperplasia, Congenital, Of Adrenal Cortex With Male Pseudohermaphroditism Congenital Adrenal Hyperplasia Lipoid Adrenal Hyperplasia, Congenital Congenital Adrenal Hyperplasia, Lipoid AH1 Congenital Lipoid Hyperplasia Of Adrenal Cortex With Male Pseudohermaphroditism Adrenal Hyperplasia Congenital Hyperplasia, Adrenal, Lipoid, Congenital Congenital Adrenogenital Disorders Associated With Enzyme Deficiency Congenital Adrenal Cortical Hyperplasia Congenital Adrenal Gland Hyperplasia Congenital Adrenogenital Syndrome Congenital Hyperadrenocorticism Congenital Adrenogenitalism Congenital Female Adrenal Pseudohermaphroditism
Prostatic Adenoma	Prostatic Hyperplasia Adenoma - Prostate Adenoma Of Prostate Benign Adenoma Of Prostate Prostate Adenoma Benign Prostatic Hyperplasia
Pleomorphic Adenoma	Mixed Tumor Of The Salivary Gland Adenoma Pleomorphic Adenoma, Pleomorphic Mixed Salivary Gland Tumor Mixed Tumor, Not Otherwise Specified
Barrett Esophagus	Barrett Esophagus/Esophageal Adenocarcinoma Barrett'S Esophagus Barrett Metaplasia Barrett'S Ulcer Of Esophagus Ulcerative Esophagitis Barrett'S Esophagus With Esophagitis Barrett'S Oesophagus Barretts Syndrome Barrett Syndrome BE Peptic Ulcer Of Esophagus Adenocarcinoma Of Esophagus
Prostate Disease	Prostatic Diseases Prostate Diseases
Tonsil Cancer	Tonsillar Neoplasms Malignant Neoplasm Of Faucial Tonsil Malignant Neoplasm Of Palatine Tonsil Malignant Neoplasm Of Tonsil, Faucial Malignant Tonsillar Tumor Malignant Tumor Of Tonsil Tonsillar Carcinoma Malignant Neoplasm Tonsil
Osteoporosis	Postmenopausal Osteoporosis Osteoporosis, Postmenopausal Bone Mineral Density Quantitative Trait Locus Bmnd Osteoporosis, Involutional Osteoporosis, Susceptibility To Osteoporosis, Postmenopausal, Susceptibility Bone Mineral Density Variation Qtl, Osteoporosis OSTEOP Involutional Osteoporosis Senile Osteoporosis Osteoporosis Postmenopausal Bone Mineral Density, Quantitative Trait Locus Osteoporosis, Senile Idiopathic Osteoporosis Bone Rarefaction Nos Type 1 Osteoporosis
46,Xy Sex Reversal	Swyer Syndrome Pure Gonadal Dysgenesis 46,Xy Gonadal Dysgenesis, Xy Female Type Gonadal Dysgenesis, 46,Xy 46,Xy Cgd 46,Xy Complete Gonadal Dysgenesis 46,Xy Pure Gonadal Dysgenesis 46 Xy Gonadal Dysgenesis 46, Xy Cgd 46, Xy Complete Gonadal Dysgenesis 46, Xy Pure Gonadal Dysgenesis Xy Pure Gonadal Dysgenesis Female With 46,Xy Karyotype Xy Females
Estrogen-Receptor Positive Breast Cancer
Comedo Carcinoma	Comedocarcinoma High Grade Ductal Breast Carcinoma In Situ
Prostate Adenoid Cystic Carcinoma	Adenoid Cystic Carcinoma Of Prostate Adenoid Cystic Carcinoma Of The Prostate
Vulvar Apocrine Adenocarcinoma
Castleman Disease	Angiofollicular Ganglionic Hyperplasia Angiofollicular Lymph Hyperplasia Giant Lymph Node Hyperplasia Castleman'S Disease Angiofollicular Lymph Node Hyperplasia Lymphoid Hamartoma Benign Giant Lymphoma Angiolymphoid Hyperplasia
Sweat Gland Disease	Sweat Gland Diseases
Paget Disease, Extramammary	Extramammary Paget Disease Cutaneous Paget'S Disease Paget Disease Extramammary Cutaneous Paget Disease Extramammary Paget'S Disease Paget'S Disease Of Skin Empd Extramammary Pagets Disease
Testicular Cancer	Testis Cancer Testicular Carcinoma Testicular Neoplasms Malignant Neoplasm Of Testis Childhood Neoplasm Of The Testis Neoplasm Of Testis Pediatric Testicular Neoplasm Testicular Tumor Testis Neoplasm Testicular Tumors Testicular Neoplasm Testicular Malignant Germ Cell Tumor Childhood Testicular Neoplasm Carcinoma Of The Testis Cancer Of Testis Malignant Neoplasm Of Testis, Nos Malignant Neoplasm Of Testis, Unspecified Malignant Tumour Of Testis Testicle Cancer Primary Malignant Neoplasm Of Testis
Severe Combined Immunodeficiency	Scid Severe Combined Immunodeficiency Disease Combined T And B Cell Inborn Immunodeficiency Immunodeficiency, Severe Combined Scid - [Severe Combined Immunodeficiencies]
Estrogen-Receptor Negative Breast Cancer
Castration-Resistant Prostate Carcinoma	Prostatic Neoplasms, Castration-Resistant
Turner Syndrome	Monosomy X Gonadal Dysgenesis Turner Type Ullrich-Turner Syndrome Bonnevie-Ullrich Syndrome Karyotype 45, X Genital Dwarfism, Turner Type Gonadal Dysgenesis Turner'S Syndrome Gonadal Dysgenesis - Turner Monosomy X Syndrome Xo Syndrome Genital Dwarfism 45, X Syndrome Bonnevie-Ulrich Syndrome Chromosome X Monosomy X Schereshevkii Turner Syndrome Turner Varny Syndrome 45,X Ts 45,X Syndrome 45,X/46,Xx Syndrome Turners Syndrome Gonadal Dysgenesis, 45,X X0 Syndrome
Gender Incongruence	Gender Dysphoria Transsexualism Gender Identify Disorder
Pleomorphic Adenoma Carcinoma	Carcinoma Ex Pleomorphic Adenoma Carcinoma In Pleomorphic Adenoma
Spermatogenic Failure 8	SPGF8
Lymph Node Carcinoma	Lymph Node Cancer Lymph Node Neoplasm Neoplasm Of Lymph Node
Non-Syndromic X-Linked Intellectual Disability Arx-Related	Arx-Related Intellectual Disability Mrxarx X-Linked Mental Retardation 29 X-Linked Mental Retardation 29 And Others X-Linked Mental Retardation 32 X-Linked Mental Retardation 33 X-Linked Mental Retardation 38 X-Linked Mental Retardation 43 X-Linked Mental Retardation 76 X-Linked Mental Retardation 87 X-Linked Mental Retardation With Or Without Seizures Arx-Related Mental Retardation, X-Linked, Type 29 And Others
Adenosquamous Carcinoma	Adenosquamous Cell Carcinoma Mixed Adenocarcinoma And Squamous Carcinoma Carcinoma Adenosquamous Carcinoma, Adenosquamous
Prostate Neuroendocrine Neoplasm	Neuroendocrine Tumor Of The Prostate
Oncocytic Breast Carcinoma
Complete Androgen Insensitivity Syndrome	Cais Complete Androgen Resistance Syndrome Androgen Insensitivity Syndrome Complete Androgen Insensitivity, Complete Androgen-Insensitivity Syndrome Testicular Feminization
Pulmonary Sclerosing Hemangioma	Pneumocytoma
Prostate Leiomyoma	Prostatic Leiomyoma
Non-Syndromic X-Linked Intellectual Disability 82	Mrx82
Telogen Effluvium
Breast Carcinoma In Situ	Carcinoma In Situ Of Breast Non-Infiltrating Carcinoma Of Breast Breast Cancer In Situ
Hypogonadotropic Hypogonadism	Klinefelter Syndrome Klinefelter'S Syndrome Xxy Syndrome Xxy Trisomy Hypogonadotropism 47, Xxy Congenital Idiopathic Hypogonadotropic Hypogonadism Isolated Congenital Gonadotropin Deficiency 47,Xxy Syndrome 47, Xxy Syndrome Klinefelters Syndrome Hypogonadism Klinefelter Syndrome In Males Klinefelter Syndrome, Unspecified Klinefelter Syndrome Karyotype 47, Xxy
Salivary Gland Carcinoma	Salivary Gland Cancer Malignant Neoplasm Of Salivary Gland Salivary Gland Neoplasms
Leukemia, Acute Myeloid	Acute Myeloid Leukemia Leukemia, Acute Myelogenous Acute Myelogenous Leukemia AML Leukemia, Acute Myeloid, Susceptibility To Acute Myeloblastic Leukemia Leukemia, Acute Myeloid, Reduced Survival In, Somatic Acute Myeloid Leukaemia Leukemia, Myelocytic, Acute Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome Secondary Aml Acute Myelocytic Leukemia Leukemia, Myeloid, Acute Acute Myeloid Leukemia, Somatic Leukemia, Acute Myeloid, Somatic Myeloid Leukemia, Acute, M4/M4eo Subtype, Somatic Acute Myeloblastic Leukaemia Acute Myelogenous Leukaemia Aml - Acute Myeloid Leukemia Acute Myeloid Leukemia With Cebpa Somatic Mutations Aml With Cebpa Somatic Mutations Inherited Acute Myeloid Leukemia Familial Aml Inherited Aml Pure Familial Aml Pure Familial Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Aml And Myelodysplastic Syndrome Acute Myeloid Leukemia, Secondary Acute Non-Lymphoblastic Leukemia Acute Non-Lymphocytic Leukemia Acute Biphenotypic Leukemia Acute Undifferentiated Leukemia Acute Myeloblastic Leukaemia With Multilineage Dysplasia Acute Myeloid Leukaemia With Multilineage Dysplasia Without Mention Of Remission Acute Myeloid Leukaemia With Myelodysplasia-Related Features
Amelogenesis Imperfecta, Type Ig	Enamel-Renal Syndrome Ers Amelogenesis Imperfecta Type 1g AI1G Enamel-Renal-Gingival Syndrome Amelogenesis Imperfecta And Gingival Fibromatosis Syndrome Aigfs Amelogenesis Imperfecta, Hypoplastic, With Nephrocalcinosis Amelogenesis Imperfecta Hypoplastic With Nephrocalcinosis Amelogenesis Imperfecta Type Ig Amelogenesis Imperfecta-Nephrocalcinosis Syndrome Amelogenesis Imperfecta 1g Hypoplastic Amelogenesis Imperfecta With Nephrocalcinosis Amelogenesis Imperfecta Nephrocalcinosis
Hypospadias 1, X-Linked	HYSP1 Hypospadias, Type 1, X-Linked
Sebaceous Gland Disease	Sebaceous Gland Anomaly Sebaceous Gland Diseases
Spermatogenic Failure	Azoospermia Spgf Spermatogenic Failure, Susceptibility To Absent Sperm Aspermatogenesis Infertility Due To Azoospermia Hypospermatogenesis Azoospermatism
Hepatocellular Carcinoma	Liver Cancer Primary Liver Cancer HCC Hepatoma Malignant Neoplasm Of Liver Liver Neoplasms Cancer, Hepatocellular Liver Cell Carcinoma Lcc Hepatoblastoma, Somatic Hepatic Cancer Primary Malignant Neoplasm Of Liver Rare Tumor Of Liver And Intrahepatic Biliary Tract Hepatocellular Carcinoma, Somatic Hepatocellular Carcinoma, Childhood Type, Somatic Hepatocellular Cancer, Somatic Ca Liver - Primary Hepatic Neoplasm Malignant Hepato-Biliary Neoplasm Malignant Neoplasm Of Liver, Not Specified As Primary Or Secondary Malignant Neoplasm Of Liver, Primary Malignant Tumor Of Liver Neoplasm Of Liver Non-Resectable Primary Hepatic Malignant Neoplasm Resectable Malignant Neoplasm Of Liver Resectable Malignant Neoplasm Of The Liver Primary Liver Carcinoma Primary Malignant Liver Neoplasm Primary Cancer Of Liver Primary Tumor Of The Liver Rare Tumor Of Liver And Ibt Hepatocellular Cancer Neoplasm Of The Liver Hepatomas Liver Neoplasm Liver Carcinoma Liver And Intrahepatic Biliary Tract Carcinoma Malignant Hepatobiliary Neoplasm Adult Primary Hepatocellular Carcinoma Hepatoblastoma Carcinoma Of Liver Malignant Liver Tumour Malignant Hepatic Tumour
Prostatic Acinar Adenocarcinoma	Acinar Prostate Adenocarcinoma
Body Mass Index Quantitative Trait Locus 11	OBESITY Obesity, Susceptibility To Leanness, Inherited Obesity, Susceptibility To, Bmiq11 Obesity, Mild, Early-Onset Obesity, Association With Obesity, Early-Onset, Susceptibility To Obesity, Severe Obesity, Severe, And Type Ii Diabetes Obesity, Late-Onset BMIQ11 Obesity Bmiq11 Obesity, Early-Onset Obesity , Susceptibility To Simple Obesity Nos Excess Fat Obesity, Not Elsewhere Classified, Body Mass Index Not Elsewhere Classified Adiposis
Non-Syndromic Posterior Hypospadias	Hypospadias, Severe Form Perineal, Scrotal Or Penoscrotal Hypospadias
Huntington Disease	Huntington'S Disease Huntington Chorea HD Huntington'S Chorea Huntington Chronic Progressive Hereditary Chorea Juvenile Huntington Disease Chronic Progressive Chorea Chronic Progressive Hereditary Chorea Hc - [Huntington Chorea] Hereditary Chorea Progressive Hereditary Chorea
Primary Cutaneous Amyloidosis	Plca Primary Localized Cutaneous Amyloidosis Familial Primary Localized Cutaneous Amyloidosis Amyloidosis Ix Lichen Amyloidosis Familial Amyloidosis, Primary Cutaneous Pca Amyloidosis 9 Amyloidosis Familial Cutaneous Lichen Fplca Familial Lichen Amyloidosis

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (65)

Cat. No.	Nom du produit	Effect	Pureté	Rare Diseases
HY-70002	Enzalutamide		99.97%	Unkown
HY-13715	Norepinephrine		99.61%	Unkown
HY-B0573B	Propranolol	Antagonist	99.91%	Yes
HY-B0573	Propranolol hydrochloride	Antagonist	99.95%	Yes
HY-N0378	D-Mannitol		99.93%	Yes
HY-Y1269	Ammonium chloride, AR, 99.5%	Inhibitor	99.69%	Yes
HY-111372	Finerenone	Antagonist	99.91%	Unkown
HY-10064	Ticagrelor	Antagonist	99.95%	Yes
HY-N0092	Inosine	Agonist	99.94%	Yes
HY-13715A	Norepinephrine hydrochloride		99.95%	Yes
HY-16985	Darolutamide	Antagonist	99.49%	Unkown
HY-14249	Bicalutamide		99.92%	Unkown
HY-16060	Apalutamide	Antagonist	99.94%	Unkown
HY-17627	Avacopan	Inhibitor	98.50%	Yes
HY-B1037	Salbutamol		99.96%	Yes
HY-13715B	Norepinephrine bitartrate monohydrate		99.96%	Unkown
HY-13613	Dutasteride		98.81%	Yes
HY-19638A	Cangrelor tetrasodium	Antagonist	99.96%	Unkown
HY-15746	Dobutamine hydrochloride	Agonist	99.60%	Yes
HY-17042	Cetirizine	Antagonist	99.79%	Yes
HY-10122	Silodosin	Antagonist	99.89%	Yes
HY-12798	Netarsudil	Inhibitor	99.94%	Unkown
HY-108449	Acoltremon	Agonist	99.13%	Unkown
HY-N0138	Theobromine	Inhibitor	99.55%	Unkown
HY-14300A	Vilanterol trifenatate	Agonist	99.82%	Unkown
HY-17497A	Acebutolol hydrochloride	Antagonist	99.70%	Unkown
HY-B0436	Salbutamol hemisulfate		98.0%	Yes
HY-12798B	Netarsudil hydrochloride	Inhibitor	99.90%	Unkown
HY-13715R	Norepinephrine (Standard)		99.97%	Unkown
HY-B0111	Drospirenone	Agonist	99.95%	Unkown
HY-17042A	Cetirizine dihydrochloride	Antagonist	99.58%	Yes
HY-14301	Olodaterol	Agonist	99.85%	Unkown
HY-B0659	Brimonidine	Agonist	99.98%	Yes
HY-13715C	Norepinephrine tartrate		99.96%	Unkown
HY-B0659A	Brimonidine tartrate	Agonist	99.68%	Yes
HY-15746A	Dobutamine	Agonist	98.75%	Yes
HY-B1114	Gliquidone	Inhibitor	99.93%	Unkown
HY-12798A	Netarsudil dimesylate		99.90%	Unkown
HY-14300	Vilanterol	Agonist	99.30%	Unkown
HY-B1486	Oxprenolol hydrochloride	Antagonist	99.86%	Unkown
HY-14301A	Olodaterol hydrochloride	Agonist	99.70%	Unkown
HY-B1276	Metaproterenol hemisulfate	Agonist	99.44%	Unkown
HY-70002B	Enzalutamide carboxylic acid		98.60%	Unkown
HY-A0295	(R)-Propranolol hydrochloride	Antagonist	99.32%	Unkown
HY-B1470	Azaperone	Antagonist	99.23%	Unkown
HY-B0004	Doxofylline		99.97%	Yes
HY-B0010D	Arformoterol tartrate	Agonist	99.63%	Unkown
HY-B1037R	Salbutamol (Standard)		99.91%	Unkown
HY-U00205	Dopexamine hydrochloride	Agonist	98.04%	Unkown
HY-B0010A	Arformoterol	Agonist	99.96%	Unkown
HY-B1016	Trapidil	Inhibitor	98.0%	Unkown
HY-17497	Acebutolol	Antagonist	99.70%	Unkown
HY-B0659S	Brimonidine-d4	Agonist	99.13%	Unkown
HY-B0484	Buflomedil hydrochloride	Antagonist	99.81%	Unkown
HY-15746B	Dobutamine tartrate	Agonist	/	Unkown
HY-19638	Cangrelor	Antagonist	/	Unkown
HY-13613R	Dutasteride (Standard)		/	Unkown
HY-B0484A	Buflomedil	Antagonist	/	Unkown
HY-B1016R	Trapidil (Standard)	Inhibitor	/	Unkown
HY-B1276A	Metaproterenol	Agonist	/	Unkown
HY-B1486A	Oxprenolol	Antagonist	/	Unkown
HY-B1562	Bopindolol		/	Unkown
HY-12502AR	Efonidipine hydrochloride monoethanolate (Standard)	Inhibitor	/	Unkown
HY-B0010E	Arformoterol maleate	Agonist	/	Unkown
HY-B1470R	Azaperone (Standard)	Antagonist	/	Unkown

Clinical Phase

Bioactive Molecules (52)

Cat. No.	Nom du produit	Effect	Pureté	Phase
HY-15758	3,3'-Diindolylmethane		99.89%	Phase 4
HY-N0378R	D-Mannitol (Standard)		99.96%	Phase 4
HY-12798C	AR-13503	Inhibitor	98.21%	Phase 4
HY-12023	GTx-007	Modulator	99.61%	Phase 4
HY-106827	Trimegestone		/	Phase 4
HY-B1037B	Salbutamol adipate		/	Phase 4
HY-10211	Tanespimycin		99.01%	Phase 3
HY-158101	BMS-986365	Degrader	99.92%	Phase 3
HY-13591	Piclidenoson		99.01%	Phase 3
HY-12365	Namodenoson	Agonist	99.56%	Phase 3
HY-50289	Sorbinil	Inhibitor	99.85%	Phase 3
HY-70006	Galeterone		99.87%	Phase 3
HY-15314	Ranirestat	Inhibitor	96.10%	Phase 3
HY-101479	Iclaprim	Inhibitor	98.92%	Phase 3
HY-70002S	Deutenzalutamide		99.80%	Phase 3
HY-135487	Sibenadet	Agonist	/	Phase 3
HY-105122	Zanoterone	Antagonist	/	Phase 3
HY-111784	Inobrodib	Inhibitor	99.95%	Phase 2
HY-138641	Bavdegalutamide	Inhibitor	99.64%	Phase 2
HY-106178	PMX-53	Antagonist	99.95%	Phase 2
HY-101978	Ciforadenant	Antagonist	99.92%	Phase 2
HY-129393	Etrumadenant	Antagonist	99.67%	Phase 2
HY-101980	Imaradenant	Antagonist	99.68%	Phase 2
HY-100186	GSK-2881078	Modulator	99.42%	Phase 2
HY-111151	AR-9281	Inhibitor	99.69%	Phase 2
HY-11027	MK-0773	Inhibitor	99.92%	Phase 2
HY-19687	Zopolrestat	Inhibitor	99.92%	Phase 2
HY-115282A	JNJ-63576253	Antagonist	99.20%	Phase 2
HY-16758	Verosudil	Inhibitor	98.22%	Phase 2
HY-109139	Taminadenant	Antagonist	99.84%	Phase 2
HY-123875A	Ralaniten triacetate	Inhibitor	98.79%	Phase 2
HY-15996	Seviteronel		99.83%	Phase 2
HY-108235A	Lanicemine dihydrochloride	Antagonist	99.94%	Phase 2
HY-111024	2,2,5,7,8-Pentamethyl-6-Chromanol		99.30%	Phase 2
HY-19436	Solabegron	Agonist	99.89%	Phase 2
HY-148804	Vemtoberant	Antagonist	98.03%	Phase 2
HY-106303	YT 146	Agonist	99.72%	Phase 2
HY-115282	JNJ-63576253 free base	Antagonist	/	Phase 2
HY-16055	Silatecan	Inhibitor	96.62%	Phase 2
HY-101555	M 16209	Inhibitor	/	Phase 2
HY-106186	GW-493838	Agonist	/	Phase 2
HY-106388	Fadolmidine	Agonist	/	Phase 2
HY-12172	MK-8141	Inhibitor	/	Phase 2
HY-124742	AR-HO47108	Inhibitor	/	Phase 2
HY-16758A	Verosudil hydrochloride	Inhibitor	/	Phase 2
HY-U00371	AR-08	Agonist	/	Phase 2
HY-N2037	Higenamine		99.31%	Phase 1
HY-103169	SCH442416	Antagonist	99.94%	Phase 1
HY-112052	Aminomalonic acid		99.97%	Phase 1
HY-16079	AZD3514	Inhibitor	99.65%	Phase 1
HY-125639	(rac)-AR-13503	Inhibitor	99.08%	Phase 1
HY-148954	PBF-999	Antagonist	98.89%	Phase 1

Inhibitory Antibodies (4)

Cat. No.	Nom du produit	Effect	Pureté	Phase
HY-P99551	Tosatoxumab		95.00%	Phase 3
HY-P99450	Avdoralimab	Inhibitor	99.25%	Phase 2
HY-P991493	AR-201	Inhibitor	/	Phase 2
HY-P990745	Izastobart	Ligand	99%	Phase 1

Pre-clinical Phase

Bioactive Molecules (747)

Cat. No.	Nom du produit	Effect	Pureté	Rare Diseases
HY-153169	6PPD-Q	Inhibitor	99.77%	Unkown
HY-145388	AU-15330	Degrader	99.89%	Unkown
HY-13248	AR-C155858	Inhibitor	99.62%	Unkown
HY-19532	ZM241385	Antagonist	99.45%	Unkown
HY-153342	Luxdegalutamide	Degrader	98.99%	Unkown
HY-W187305	MASM7		99.85%	Unkown
HY-100543	Zenidolol		99.60%	Unkown
HY-135794	11-Ketodihydrotestosterone	Agonist	99.87%	Unkown
HY-101106	AR7	Antagonist	99.38%	Unkown
HY-134923	CA77.1	Inducer	99.92%	Unkown
HY-138161	JR14a	Antagonist	99.77%	Unkown
HY-W093399	Ammonium bicarbonate,AR,99%	Inhibitor	99.0%	Unkown
HY-110136A	PMX 205 Trifluoroacetate	Antagonist	99.50%	Unkown
HY-Y0537	Potassium chloride, AR, 99.5%		99.6%	Unkown
HY-10512	AR-A014418	Inhibitor	99.21%	Unkown
HY-12111	BMS-564929	Agonist	98.28%	Unkown
HY-N0236	Corylin	Inhibitor	99.97%	Unkown
HY-110126	AR-C118925XX	Antagonist	≥99.0%	Unkown
HY-N0790	Lupeol		98.0%	Unkown
HY-131498	MOCAc-PLGL(Dpa)AR	Substrate	99.86%	Unkown
HY-N1943	Ailanthone	Inhibitor	99.93%	Unkown
HY-P4931	Mca-KPLGL-Dap(Dnp)-AR-NH2		99.30%	Unkown
HY-101986	BIIE-0246	Antagonist	99.10%	Unkown
HY-W015061	Phenylacetylglycine		99.38%	Unkown
HY-158113	CBPD-409	Degrader	99.38%	Unkown
HY-Y0332B	Potassium dihydrogen phosphate, AR,99.5%		99.7%	Unkown
HY-W011927	4,4'-Sulfonyldiphenol		99.81%	Unkown
HY-110136	PMX 205	Antagonist	99.54%	Unkown
HY-116522	AR420626		98.40%	Unkown
HY-10547	OSU-03012		99.80%	Unkown
HY-N0166	Gramine		99.80%	Unkown
HY-130492	ARCC-4	Inhibitor	99.88%	Unkown
HY-N0092S2	Inosine-13C5	Agonist	99.90%	Unkown
HY-153918	(R)-SKBG-1	Inhibitor	99.68%	Unkown
HY-176521	AR/BRD4 RIPTAC-1		98.65%	Unkown
HY-13981	Ligandrol		99.93%	Unkown
HY-19334	L755507	Agonist	98.89%	Unkown
HY-Y0261A	Ammonium sulphate,≥99.0%,AR		99.30%	Unkown
HY-149433	BWA-522		98.04%	Unkown
HY-N0819	Raddeanin A		98.68%	Unkown
HY-148141	JPE-1375	Antagonist	99.96%	Unkown
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	Unkown
HY-114936	Piericidin A	Inhibitor	99.83%	Unkown
HY-148771	MTX-23		99.79%	Unkown
HY-173626	EN1441	Degrader	99.67%	Unkown
HY-78055	2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol		99.76%	Unkown
HY-145479	PROTAC AR-V7 degrader-1	Inhibitor	98.19%	Unkown
HY-100554	BMY 7378		99.92%	Unkown
HY-15564	AR 231453	Agonist	99.58%	Unkown
HY-161409	SC912		99.13%	Unkown
HY-B0845	Prochloraz		99.85%	Unkown
HY-13265	AR-42	Inducer	98.52%	Yes
HY-145237	BM213		99.81%	Unkown
HY-110012	SCH-202676 hydrobromide	Modulator	98.85%	Unkown
HY-116501	VPC-14449	Inhibitor	99.51%	Unkown
HY-159190	HRX-0233	Inhibitor	98.92%	Unkown
HY-W110883	Xylenol orange tetrasodium salt, IND		IND	Unkown
HY-30756	tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate		99.89%	Unkown
HY-103190	MRS1220	Antagonist	99.52%	Unkown
HY-124292	Honokiol DCA	Inhibitor	98.01%	Unkown
HY-169841	IHCH-7086	Agonist	98.96%	Unkown
HY-173634	Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan	Inhibitor	99.95%	Unkown
HY-P5506	C5a Receptor agonist, W5Cha	Agonist	99.13%	Unkown
HY-161369	CBPD-268	Degrader	99.23%	Unkown
HY-123012	Lubabegron	Modulator	98.40%	Unkown
HY-150102	EPI-7170	Antagonist	99.86%	Unkown
HY-153152	DPTN dihydrochloride	Antagonist	98.47%	Unkown
HY-100348	EPI-001		99.34%	Unkown
HY-W011927S	4,4'-Sulfonyldiphenol-d8		99.21%	Unkown
HY-N2122	Neoisoliquiritin		99.74%	Unkown
HY-N4089	Quercetin 3-gentiobioside	Inhibitor	99.56%	Unkown
HY-109070	Ralaniten	Antagonist	99.57%	Unkown
HY-117669	VPC-14228	Inhibitor	99.36%	Unkown
HY-N2908	Atraric acid		99.97%	Unkown
HY-145709	Ar-V7-IN-1	Inhibitor	98.02%	Unkown
HY-112256	ACP-105	Modulator	98.92%	Unkown
HY-114402	ARD-69	Degrader	99.61%	Unkown
HY-132292	ARD-2128	Inhibitor	99.17%	Unkown
HY-70002S1	Enzalutamide-d6	Antagonist	99.85%	Unkown
HY-N2673	5-Heptadecylresorcinol	Activator	99.83%	Unkown
HY-W013249	Boc-piperazine-benzoic acid		97.42%	Unkown
HY-136242	UT-34	Degrader	98.09%	Unkown
HY-156751A	GDC-2992	Degrader	99.38%	Unkown
HY-102076	0990CL		≥98.0%	Unkown
HY-108250	(R)-Bicalutamide	Antagonist	99.95%	Unkown
HY-112257	S-23	Modulator	99.63%	Unkown
HY-141487	CLP-3094	Inhibitor	99.92%	Unkown
HY-162412	PROTAC AR/AR-V7 degrader-1		99.72%	Unkown
HY-164373	SC428		98.0%	Unkown
HY-170329	PROTAC AR Degrader-8		99.98%	Unkown
HY-N6703	ar-Turmerone	Inducer	99.00%	Unkown
HY-110060	NDT 9513727	Antagonist	99.35%	Unkown
HY-117992	BR103		99.66%	Unkown
HY-160020	ET516	Inhibitor	99.13%	Unkown
HY-B1876	Nicosulfuron		97.27%	Unkown
HY-N0475	Triptophenolide		99.98%	Unkown
HY-19337	Ketodarolutamide	Antagonist	98.72%	Unkown
HY-133020	ARD-266	Inhibitor	99.94%	Unkown
HY-156111	ARD-1676	Degrader	99.36%	Unkown
HY-139644	MIPS521	Agonist	98.21%	Unkown
HY-101300	Cirazoline hydrochloride	Agonist	99.56%	Unkown
HY-103245	Cl-4AS-1	Agonist	99.64%	Unkown
HY-147291	VPC-70063		99.92%	Unkown
HY-18775	N6-(4-Hydroxybenzyl)adenosine		99.84%	Unkown
HY-D1606	BODIPY FL prazosin	Inhibitor	99.71%	Unkown
HY-P10639	C5aR2 agonist P32	Agonist	99.17%	Unkown
HY-43962	CS-1-65		99.54%	Unkown
HY-78542	Deshydroxyethoxy ticagrelor	Inhibitor	98.82%	Unkown
HY-B1421	Ractopamine hydrochloride	Agonist	99.2%	Unkown
HY-N5124	Meloside A	Inhibitor	98.72%	Unkown
HY-45219	((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate		98.90%	Unkown
HY-Y0261AS1	Ammonium sulphate,≥99.0%,AR-N152		99.30%	Unkown
HY-18776	A2AR-agonist-1	Agonist	99.90%	Unkown
HY-103180	2'-MeCCPA	Agonist	99.80%	Unkown
HY-103183	CV1808	Agonist	≥98.0%	Unkown
HY-112895	UT-155	Antagonist	99.55%	Unkown
HY-120208	MK204	Inhibitor	99.7%	Unkown
HY-130992	Androgen receptor antagonist 1	Antagonist	99.64%	Unkown
HY-147907	Adenosine receptor inhibitor 1	Inhibitor	98.29%	Unkown
HY-149862	ARD-2051	Degrader	98.57%	Unkown
HY-15844	AG-825		98.13%	Unkown
HY-N7045	Isosilybin B		99.32%	Unkown
HY-I0108	2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol oxalate		98.0%	Unkown
HY-19319	MI-136		99.04%	Unkown
HY-16985S	Darolutamide-d4	Antagonist	98.58%	Unkown
HY-103162	ANR94	Antagonist	98.91%	Unkown
HY-119993	AR03	Inhibitor	99.1%	Unkown
HY-122917	Danshenol A	Inhibitor	99.67%	Unkown
HY-126076A	VPC-80051		99.77%	Unkown
HY-171978A	LM-189 free base	Agonist	99.70%	Unkown
HY-N0092S	Inosine-2,8-d2	Agonist	99.69%	Unkown
HY-N1731	2′-Hydroxy-5′-methoxyacetophenone	Inhibitor	99.96%	Unkown
HY-W007367	2,6-Dichloropurine		99.81%	Unkown
HY-101393A	CGP 12177 hydrochloride	Modulator	99.69%	Unkown
HY-117971	BVT173187	Inhibitor	99.97%	Unkown
HY-120006A	(rel)-AR234960	Agonist	98.95%	Unkown
HY-131388	ABM-14		98.10%	Unkown
HY-133045	VHL Ligand 8		98.04%	Unkown
HY-139659	ARD-61		99.57%	Unkown
HY-160777	VNPP433-3β		98.01%	Unkown
HY-163340	GA32	Inhibitor	99.67%	Unkown
HY-B0573S	Propranolol-d7 hydrochloride	Antagonist	98.47%	Unkown
HY-B1866	Linuron	Antagonist	99.88%	Unkown
HY-E70333	Microgranulated pectolytic enzyme		/	Unkown
HY-N0378S2	D-Mannitol-13C6		98.0%	Unkown
HY-N7043	Isosilybin A		99.63%	Unkown
HY-113430	5-n-Heneicosylresorcinol	Inhibitor	98.0%	Unkown
HY-151239	ONT-993	Inhibitor	99.85%	Unkown
HY-120018	VPC-13566	Inhibitor	99.92%	Unkown
HY-12122A	AR-C102222 hydrochloride	Inhibitor	99.83%	Unkown
HY-130845A	AR antagonist 1 hydrochloride	Antagonist	99.53%	Unkown
HY-136596	Apalutamide-COOH		99.76%	Unkown
HY-159639	BAY-2925976	Inhibitor	99.14%	Unkown
HY-17042S1	Cetirizine-d8	Antagonist	96.46%	Unkown
HY-18967	Caficrestat	Inhibitor	99.74%	Unkown
HY-B0846	Dimethomorph	Inhibitor	99.10%	Unkown
HY-N0138S1	Theobromine-d3	Inhibitor	99.78%	Unkown
HY-135794S	11-Ketodihydrotestosterone-d3	Agonist	≥99.90%	Unkown
HY-164552	ZNU-IMB-Z15		99.03%	Unkown
HY-W877989	BWA-522 intermediate-1		99.27%	Unkown
HY-N0378S3	D-Mannitol-2-13C		99.95%	Unkown
HY-B0573BS	Propranolol-d7	Antagonist	≥99.0%	Unkown
HY-103246	TFM-4AS-1		99.96%	Unkown
HY-111809	N6-Ethyladenosine	Agonist	99.90%	Unkown
HY-135483A	AR-R17779 hydrochloride	Agonist	99.0%	Unkown
HY-135732	SK33	Antagonist	99.98%	Unkown
HY-147545	A1AR antagonist 6	Antagonist	98.13%	Unkown
HY-147908	Adenosine receptor inhibitor 2	Inhibitor	99.08%	Unkown
HY-15011	L-372662	Antagonist	99.24%	Unkown
HY-156084	LL-K9-3		99.2%	Unkown
HY-161741	VinclozolinM2-2204	Degrader	98.00%	Unkown
HY-162325	WJ-39		99.60%	Unkown
HY-168299	AR ligand-30	Ligand	/	Unkown
HY-169387	YT 6-2-PEG3-C2-NH2	Control	99.50%	Unkown
HY-175231	ST171	Agonist	99.34%	Unkown
HY-175652	AZD9750	Degrader	98.15%	Unkown
HY-B0573S1	Propranolol-d7 (ring-d7)	Antagonist	99.80%	Unkown
HY-B1037S	Salbutamol-d3		98.68%	Unkown
HY-B1562B	Bopindolol malonate		98.30%	Unkown
HY-B1866S	Linuron-d6		99.76%	Unkown
HY-N0378S1	D-Mannitol-13C		99.9%	Unkown
HY-P5123A	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg TFA	Activator	98.75%	Unkown
HY-Y0261AS	Ammonium sulphate-d8		99.6%	Unkown
HY-Y0827	Barium carbonate,AR,99%		99%	Unkown
HY-76819	Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate		98.47%	Unkown
HY-W017742	Rolapitant Intermediate		98.0%	Unkown
HY-W341547	3,4-Dihydro-6,7-isoquinolinediol	Agonist	98.71%	Unkown
HY-W744625	Olodaterol-d3 hydrochloride		99.9%	Unkown
HY-101039A	AR-M 1000390 hydrochloride	Agonist	98.20%	Unkown
HY-101854	N6-(2-Phenylethyl)adenosine	Agonist	99.41%	Unkown
HY-103203	ST91	Agonist	99.75%	Unkown
HY-106954	Upidosin	Antagonist	99.48%	Unkown
HY-123012A	Lubabegron fumarate	Antagonist	98.44%	Unkown
HY-14250	PF-998425	Antagonist	98.63%	Unkown
HY-147100	α1A-AR Degrader 9c	Inhibitor	99.60%	Unkown
HY-151604	Transketolase-IN-3	Inhibitor	98.94%	Unkown
HY-162702	AZ'3137	Degrader	99.90%	Unkown
HY-163940	LX1		99.13%	Unkown
HY-17042S	Cetirizine-d4	Antagonist	99.10%	Unkown
HY-170820	XYD049	Inhibitor	99.46%	Unkown
HY-171978	LM-189	Agonist	96.58%	Unkown
HY-178259	α2AR agonist 2	Antagonist	99.46%	Unkown
HY-179226	AP-7-168	Inhibitor	99.89%	Unkown
HY-184126	JZY3221	Inhibitor	98.01%	Unkown
HY-77734	AR-C133913XX		99.76%	Unkown
HY-B1001A	Todralazine hydrochloride	Inhibitor	99.87%	Unkown
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	99.23%	Unkown
HY-RS00532	AKR1B1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-130845	AR antagonist 1	Antagonist	99.03%	Unkown
HY-RS00884	Ar Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS17235	Akr1b1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W110146	(3aS,4S,6aR)-Biotin-PEG4-Alkyne		99.93%	Unkown
HY-111848	PROTAC AR Degrader-4	Inhibitor	/	Unkown
HY-111848A	PROTAC AR Degrader-4 TFA	Inhibitor	99.26%	Unkown
HY-157491	K2-B4-5e	Degrader	/	Unkown
HY-184124	JZY3032	Inhibitor	/	Unkown
HY-111372A	(Rac)-Finerenone	Antagonist	99.66%	Unkown
HY-133127	AR453588	Activator	99.84%	Unkown
HY-14249S	Bicalutamide-d4		99.5%	Unkown
HY-B1486S	Oxprenolol-d7 hydrochloride	Antagonist	98.25%	Unkown
HY-101986A	BIIE-0246 hydrochloride	Antagonist	99.33%	Unkown
HY-103177	PSB-10 hydrochloride	Inhibitor	/	Unkown
HY-108449S	Acoltremon-d3		99.58%	Unkown
HY-111145	RD162	Antagonist	99.69%	Unkown
HY-111372S1	Finerenone-d5	Antagonist	99.71%	Unkown
HY-119996A	AR-C141990 hydrochloride	Inhibitor	98.2%	Unkown
HY-123358	AR-H049020XX		/	Unkown
HY-12715S	Yohimbine-13C,d3	Antagonist	99.0%	Unkown
HY-14250A	(Rac)-PF-998425	Antagonist	99.45%	Unkown
HY-14296A	PF-610355 (hydrochloride)	Agonist	/	Unkown
HY-144127	AR antagonist 3	Antagonist	99.96%	Unkown
HY-147261	B026	Inhibitor	/	Unkown
HY-151596	MAO-A/5-HT2AR-IN-1	Inhibitor	99.71%	Unkown
HY-154959A	(9R,12aR)-AZD4747	Control	98.90%	Unkown
HY-16060S	Apalutamide-d4	Antagonist	99.93%	Unkown
HY-16060S1	Apalutamide-d3		/	Unkown
HY-160887	FPT	Agonist	98.06%	Unkown
HY-162620	α2A-AR agonist 1	Agonist	99.92%	Unkown
HY-171048	GTx-027	Modulator	99.61%	Unkown
HY-173703	β-Glu-PAB(CH2NH2)-Exatecan	Inhibitor	96.60%	Unkown
HY-176068	3-Cl-Pyridine-amide-acrylaldehyde-piperazine		99.30%	Unkown
HY-176521A	AR/BRD4 RIPTAC-1 TFA		99.61%	Unkown
HY-179433	PROTAC AR Degrader-12		/	Unkown
HY-90009D	(6S,12aR)-Tadalafil	Inhibitor	99.48%	Unkown
HY-B0010AS	Formoterol-d3	Agonist	99.60%	Unkown
HY-B1037S3	Salbutamol-d9 acetate		99.48%	Unkown
HY-B1114S	Gliquidone-d6		99.42%	Unkown
HY-D1379	Azophloxine		99.71%	Unkown
HY-N0166R	Gramine (Standard)		98.95%	Unkown
HY-N0378S	D-Mannitol-d8		/	Unkown
HY-N4232	Clematichinenoside AR	Inducer	99.74%	Unkown
HY-N7962	Cornoside	Inhibitor	96.0%	Unkown
HY-N9917	Galloylalbiflorin	Antagonist	95.0%	Unkown
HY-P5213	Vasopressin Dimer (parallel) TFA	Activator	99.55%	Unkown
HY-RS01751	C5AR2 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W004425	DMPX	Antagonist	99.66%	Unkown
HY-W015061S	N-(Phenylacetyl-d5)glycine		≥99.0%	Unkown
HY-W653723	N-Nitrosodicyclohexylamine	Antagonist	99.0%	Unkown
HY-111372S	Finerenone-d3		/	Unkown
HY-121837	β2AR-IN-15	Antagonist	98.84%	Unkown
HY-133086	Hydrodolasetron		98.96%	Unkown
HY-134555	A3AR antagonist 4	Antagonist	99.98%	Unkown
HY-138089	17β-Hydroxy exemestane		98.21%	Unkown
HY-16060S2	Apalutamide-13C,d3	Antagonist	99.90%	Unkown
HY-400766	BWA-522 intermediate-2		99.87%	Unkown
HY-B1037S2	Salbutamol-d9		98.42%	Unkown
HY-RS21501	C3ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS29512	AP1AR Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W076756	4-Piperidyl N-(2-biphenyl)carbamate	Antagonist	99.97%	Unkown
HY-W157299	2-(Bromomethyl)-1-fluoro-3-methoxybenzene		/	Unkown
HY-Z7733	O-Desmethylcarvedilol	Inhibitor	97.4%	Unkown
HY-14561	Idazoxan		/	Unkown
HY-B1470S	Azaperone-d4	Antagonist	95.83%	Unkown
HY-N0092S1	Inosine-13C	Agonist	/	Unkown
HY-101514	β3-AR agonist 1	Agonist	/	Unkown
HY-125839	OP-3633	Antagonist	/	Unkown
HY-133127A	AR453588 hydrochloride	Activator	/	Unkown
HY-148804A	Vemtoberant mesylate	Antagonist	/	Unkown
HY-183667	JNJ-pan-AR	Inhibitor	/	Unkown
HY-N0138S	Theobromine-d6	Inhibitor	98.0%	Unkown
HY-100348R	EPI-001 (Standard)		/	Unkown
HY-101039	AR-M 1000390	Agonist	/	Unkown
HY-101393	CGP 12177	Modulator	/	Unkown
HY-101986C	BIIE-0246 dihydrochloride	Antagonist	/	Unkown
HY-10273	Atecegatran metoxil	Inhibitor	/	Unkown
HY-10275A	Atecegatran TFA	Inhibitor	/	Unkown
HY-103203A	ST91 free base	Agonist	/	Unkown
HY-10512S	AR-A014418-d3	Inhibitor	/	Unkown
HY-106388A	Fadolmidine hydrochloride	Agonist	/	Unkown
HY-106684A	Ridazolol hydrochloride	Antagonist	/	Unkown
HY-106769A	(3aR,9aR)-Fluparoxan hydrochloride		/	Unkown
HY-106915	SG-210	Inhibitor	/	Unkown
HY-107018	AR-A 2	Antagonist	/	Unkown
HY-108235AS1	Lanicemine-d5 dihydrochloride	Antagonist	/	Unkown
HY-108633	BYK 49187	Inhibitor	/	Unkown
HY-109139A	Taminadenant mesylate	Antagonist	/	Unkown
HY-110202	MRS5698	Agonist	/	Unkown
HY-111044	(+)-JNJ-37654032	Modulator	/	Unkown
HY-111231	CH4933468	Antagonist	/	Unkown
HY-111372B	(R)-Finerenone	Antagonist	99.70%	Unkown
HY-112567	TRR469	Modulator	/	Unkown
HY-113526	AR-12463	Inhibitor	/	Unkown
HY-113701	CH5137291	Antagonist	/	Unkown
HY-113781	Ractopamine	Agonist	/	Unkown
HY-113781S	Ractopamine-d6	Agonist	/	Unkown
HY-115940	Aldose reductase-IN-2	Inhibitor	/	Unkown
HY-115977	Aldose reductase-IN-3	Inhibitor	/	Unkown
HY-116042	FSCPX	Antagonist	99.72%	Unkown
HY-116379	RS-100329	Antagonist	/	Unkown
HY-116982	BMY 7378 free base		/	Unkown
HY-117239	SB-206606	Agonist	/	Unkown
HY-117435	CIDD 0067106	Inhibitor	/	Unkown
HY-117527	L742791	Agonist	/	Unkown
HY-117781	GW-5823	Agonist	/	Unkown
HY-117953	RU 59063	Inhibitor	98.61%	Unkown
HY-118260	Phendioxan		/	Unkown
HY-118678	MRS1186	Antagonist	/	Unkown
HY-119088	Estrogen receptor modulator 12	Modulator	/	Unkown
HY-119170	BMS-779333	Antagonist	/	Unkown
HY-119436	LG-120907	Antagonist	/	Unkown
HY-119806	TMPPAA	Agonist	/	Unkown
HY-119996	AR-C141990	Inhibitor	/	Unkown
HY-120090	MRS1177	Antagonist	/	Unkown
HY-120652	A3AR antagonist 3	Antagonist	/	Unkown
HY-12099	A3AR antagonist 2	Antagonist	/	Unkown
HY-121094	Androgen receptor allosteric antagonist 1	Antagonist	/	Unkown
HY-121588	IMTPPE	Inhibitor	/	Unkown
HY-122048	AR-C67085	Antagonist	/	Unkown
HY-122108	Ilicicolin A	Inducer	/	Unkown
HY-122231	MRS3558	Agonist	/	Unkown
HY-122963	Danshenol B		/	Unkown
HY-123059A	(2S,3S)-Zenidolol hydrochloride	Antagonist	/	Unkown
HY-123163	JNJ-1250132		/	Unkown
HY-123308	VPC13163	Inhibitor	/	Unkown
HY-123310	JNJ-26146900	Antagonist	/	Unkown
HY-124270	Sibenadet hydrochloride	Agonist	/	Unkown
HY-124412	Paynantheine	Agonist	/	Unkown
HY-124585	Y08060	Inhibitor	/	Unkown
HY-125065	MK-4541		/	Unkown
HY-125627	CP-394531	Antagonist	/	Unkown
HY-126464	Estromustine	Modulator	/	Unkown
HY-12798CR	AR-13503 (Standard)	Inhibitor	/	Unkown
HY-12798E	(R)-AR-13503	Control	98.20%	Unkown
HY-128934	Antitumor agent-2		/	Unkown
HY-129761	AR 17048	Activator	/	Unkown
HY-130190	Butopamine	Activator	/	Unkown
HY-133044	Boc-Pip-alkyne-Ph-COOH		/	Unkown
HY-133046	VHL Ligand-Linker Conjugates 17		/	Unkown
HY-133862	SCH-202676		99.46%	Unkown
HY-13613S	Dutasteride-13C6		/	Unkown
HY-13613S2	Dutasteride-13C,15N,d		/	Unkown
HY-136960	β2AR antagonist 1	Antagonist	/	Unkown
HY-139046	MEPB	Modulator	/	Unkown
HY-139104	Thailanstatin D		/	Unkown
HY-139694	hA3AR agonist 1	Agonist	/	Unkown
HY-139970	VPC-13789	Inhibitor	/	Unkown
HY-141865	Adenosine receptor antagonist 1	Antagonist	/	Unkown
HY-14249S1	(R)-Bicalutamide-d5		/	Unkown
HY-142923	AR antagonist 2	Antagonist	/	Unkown
HY-14300AS	Vilanterol-d4 trifenatate	Agonist	/	Unkown
HY-14300D	Vilanterol acetate	Agonist	/	Unkown
HY-143471	WNY0824		/	Unkown
HY-143535	HG122		/	Unkown
HY-144115	A1AR antagonist 1	Antagonist	/	Unkown
HY-144116	A1AR antagonist 2	Antagonist	/	Unkown
HY-144672	A2A receptor antagonist 2	Antagonist	/	Unkown
HY-145308	Heterobivalent ligand-1		/	Unkown
HY-145406	IHCH-3064	Inhibitor	/	Unkown
HY-145480	Silodosin Glucuronide sodium		/	Unkown
HY-145698	UCSF678	Agonist	/	Unkown
HY-145699	UCSF686		/	Unkown
HY-145706	A2A/A1 AR antagonist-1	Antagonist	/	Unkown
HY-145862	5-HT6/5-HT2AR antagonist-1	Agonist	/	Unkown
HY-146026	Androgen receptor antagonist 3	Antagonist	/	Unkown
HY-146027	Androgen receptor antagonist 4	Antagonist	/	Unkown
HY-146397	TD-802	Inhibitor	/	Unkown
HY-146456	A1AR antagonist 3	Antagonist	/	Unkown
HY-146457	A3AR antagonist 1	Antagonist	/	Unkown
HY-146478	A1/A3 AR antagonist 1	Antagonist	/	Unkown
HY-146479	A1/A3 AR antagonist 2		/	Unkown
HY-146494	Androgen receptor antagonist 5	Antagonist	/	Unkown
HY-146979	hA2A/hCA XII modulator 1		/	Unkown
HY-147541	A2A/A3 AR antagonist-1	Antagonist	/	Unkown
HY-147543	A1AR antagonist 4	Antagonist	/	Unkown
HY-147544	A1AR antagonist 5	Antagonist	/	Unkown
HY-147585	C5aR-IN-1		/	Unkown
HY-147586	C5aR-IN-2		/	Unkown
HY-147587	C5aR-IN-3		/	Unkown
HY-147706	AR524		/	Unkown
HY-147875	Aldose reductase-IN-6	Inhibitor	/	Unkown
HY-148252	ADRA1D receptor antagonist 1 free base	Antagonist	/	Unkown
HY-148300	AR-C66096	Antagonist	/	Unkown
HY-148361	Fluorogen binding modulator-1		/	Unkown
HY-148524	β2AR/M-receptor agonist-1		/	Unkown
HY-148525	PF-4348235		/	Unkown
HY-148526	β2AR/M3-receptor agonist-1	Agonist	/	Unkown
HY-148533	β2AR agonist /M-receptor antagonist-1		/	Unkown
HY-148777	A031	Degrader	/	Unkown
HY-14897	Rezatomidine	Agonist	/	Unkown
HY-149434	PROTAC AR-NTD degrader 1	Inducer	/	Unkown
HY-149727	β2AR agonist 2	Agonist	/	Unkown
HY-149728	β2AR agonist 3	Agonist	/	Unkown
HY-149914	WCA-814	Degrader	/	Unkown
HY-149916	A2AR-antagonist-1	Antagonist	96.68%	Unkown
HY-150025	(4aS,8aR)-NPD-001		/	Unkown
HY-150812	VHL Ligand 23		/	Unkown
HY-150878	AR ligand-4	Ligand	/	Unkown
HY-151266	AR antagonist 4	Antagonist	/	Unkown
HY-151899	A3AR modulator 1	Agonist	/	Unkown
HY-152524	Androgen receptor antagonist 7	Antagonist	/	Unkown
HY-153157	MRS542		/	Unkown
HY-153333	A1/A3 AR antagonist 3	Antagonist	/	Unkown
HY-153519	WWL0245	Inhibitor	/	Unkown
HY-153718	KI-ARv-03	Inhibitor	/	Unkown
HY-155183	A3AR agonist 1	Agonist	/	Unkown
HY-155184	A3AR agonist 2	Agonist	/	Unkown
HY-155543	Anticancer agent 135	Antagonist	/	Unkown
HY-155666	YXG-158	Degrader	/	Unkown
HY-155772	LUF7690		/	Unkown
HY-156751	(Rac)-GDC-2992	Degrader	/	Unkown
HY-156983	MRS 5980		/	Unkown
HY-157425	5-HT2CR agonist 1	Agonist	/	Unkown
HY-157455	AR antagonist 5		/	Unkown
HY-157796	β2AR agonist 4	Agonist	/	Unkown
HY-158057	A2AR/A2BR antagonist 1	Antagonist	/	Unkown
HY-158179	A3AR agonist 3	Agonist	/	Unkown
HY-158180	A3AR agonist 4	Agonist	/	Unkown
HY-158181	A3AR agonist 5	Agonist	/	Unkown
HY-159096	Apoptosis inducer 21	Inducer	/	Unkown
HY-159739	M17-B15	Inhibitor	/	Unkown
HY-159889	hA3AR agonist 2	Agonist	/	Unkown
HY-159922	AR antagonist 9	Antagonist	/	Unkown
HY-160221	PROTAC AR Degrader-7		/	Unkown
HY-160262	PROTAC AR/BET protein degrader-1	Degrader	/	Unkown
HY-160547	PROTAC AR Degrader-5	Degrader	/	Unkown
HY-16060S3	Apalutamide-d7	Antagonist	/	Unkown
HY-160680	AR antagonist 6	Inhibitor	/	Unkown
HY-160692	AR antagonist 7	Antagonist	/	Unkown
HY-160777A	VNPP433-3β dihydrochloride		/	Unkown
HY-160777B	VNPP433-3β hydrochloride		/	Unkown
HY-161717	MRS5663	Agonist	/	Unkown
HY-161718	MRS8028	Agonist	/	Unkown
HY-161810	MRS8247	Modulator	/	Unkown
HY-161836	α2AR agonist 1	Agonist	/	Unkown
HY-162083	CB2R/5-HT1AR agonist 1	Agonist	/	Unkown
HY-162241	SJH1-62B		/	Unkown
HY-162585	5-HT1AR agonist 1	Agonist	/	Unkown
HY-162659	β2AR ligand 1		/	Unkown
HY-163363	β-AR antagonist 2	Antagonist	/	Unkown
HY-163378	C5aR1 antagonist 1	Antagonist	/	Unkown
HY-163379	C5aR1 antagonist 2	Antagonist	/	Unkown
HY-163485	AR antagonist 8	Inhibitor	/	Unkown
HY-163510	AR/AR-V7-IN-1	Inhibitor	/	Unkown
HY-163632	EGFR-IN-112	Inhibitor	/	Unkown
HY-163641	AR Degrader-1	Degrader	/	Unkown
HY-163813	AR Degrader-2	Degrader	/	Unkown
HY-163978	YGZ-331	Activator	/	Unkown
HY-165509	DU172	Ligand	/	Unkown
HY-16741	Erlosiban	Antagonist	/	Unkown
HY-167905	ATL444	Antagonist	/	Unkown
HY-168141	Androgen receptor antagonist 11	Antagonist	/	Unkown
HY-168168	(5aS,6R,6aR)-MK-8666		/	Unkown
HY-168344	CACPD2011a-0001278239	Activator	/	Unkown
HY-168697	AR ligand-37	Ligand	/	Unkown
HY-169349	Androgen receptor antagonist 12	Antagonist	/	Unkown
HY-169385	ATC-324	Degrader	/	Unkown
HY-169386	YT 6-2 analog-1	Control	/	Unkown
HY-169388	YT 6-2	Control	/	Unkown
HY-169394	5-HT1AR agonist 2		/	Unkown
HY-169967	AR ligand-31		/	Unkown
HY-169975	tert-Butyl 4-(4-(piperazin-1-ylmethyl)piperidin-1-yl)benzoate		/	Unkown
HY-169976	E3 Ligase Ligand-linker Conjugate 140		/	Unkown
HY-170303	AR ligand-32	Ligand	/	Unkown
HY-170304	E3 ligase Ligand 44		/	Unkown
HY-170305	E3 Ligase Ligand-linker Conjugate 145		/	Unkown
HY-170330	AR ligand-33	Ligand	/	Unkown
HY-17042AS1	Cetirizine-d8 dihydrochloride	Antagonist	99.64%	Unkown
HY-170448	PROTAC AR Degrader-9	Degrader	/	Unkown
HY-170449	E3 ligase Ligand 48		/	Unkown
HY-170450	AR ligand-38	Ligand	/	Unkown
HY-170948	A2AR modulator-1	Modulator	/	Unkown
HY-170951	AR antagonist 10	Antagonist	/	Unkown
HY-171467	MRS7799	Antagonist	/	Unkown
HY-171808	ITRI-90		/	Unkown
HY-171809	AR ligand 42	Ligand	/	Unkown
HY-172612	AR antagonist 13	Antagonist	/	Unkown
HY-172624	AR antagonist 14	Antagonist	/	Unkown
HY-172954	Androgen receptor ligand 1		/	Unkown
HY-172956	E3 Ligase Ligand-linker Conjugate 188		/	Unkown
HY-172995	RS130-180	Agonist	/	Unkown
HY-173044	5-HT1AR/5-HT6R ligand-1		/	Unkown
HY-173045	5-HT5AR/5-HT6R ligand-1	Ligand	/	Unkown
HY-173372	PROTAC AR Degrader-10	Degrader	/	Unkown
HY-173373	AR ligand-39	Ligand	/	Unkown
HY-173409	AR antagonist 11		/	Unkown
HY-173474	ERβ agonist-1		/	Unkown
HY-173498	AR ligand 40	Antagonist	/	Unkown
HY-173559	AR antagonist 12	Antagonist	/	Unkown
HY-173635	Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB		/	Unkown
HY-173640	ID11916		/	Unkown
HY-174157	AR493	Activator	/	Unkown
HY-174377	PeS-9		/	Unkown
HY-174391	AR antagonist 15	Inducer	/	Unkown
HY-174413	A2AAR antagonist 3	Antagonist	/	Unkown
HY-174466	5-HT2AR ligand 1		/	Unkown
HY-175178	Arrestin-3 modulator-1	Modulator	/	Unkown
HY-175285	5-HT2AR-IN-1	Inhibitor	/	Unkown
HY-175455	LYA914		/	Unkown
HY-175456	AR-DBD ligand-1		/	Unkown
HY-175669	ANO1-IN-5	Inhibitor	/	Unkown
HY-175790	AR/BET ligand-1	Ligand	/	Unkown
HY-175791	Ethyl-Cha-thalidomide-NH2		/	Unkown
HY-175906	AR ligand-45	Ligand	/	Unkown
HY-175981	Paclitaxel-bromothiophene		/	Unkown
HY-176060	Platelet aggregation-IN-3	Ligand	/	Unkown
HY-176067	LO-4-25	Degrader	/	Unkown
HY-176128	BWA-6047		/	Unkown
HY-176225	BY13		/	Unkown
HY-17627S1	Avacopan-d4	Inhibitor	/	Unkown
HY-176714	VUF26034	Ligand	/	Unkown
HY-176717	5-HT1AR agonist 3	Agonist	/	Unkown
HY-176863	Di(5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl)-benzene-amide-PEG4-ester-2,3,5,6-F-Ph		/	Unkown
HY-177670	Zintevir	Inhibitor	/	Unkown
HY-177670A	Zintevir sodium	Inhibitor	/	Unkown
HY-177694	PROTAC AR Degrader-11	Degrader	/	Unkown
HY-178030	CAXII-IN-3		/	Unkown
HY-178148	AR antagonist 17	Antagonist	/	Unkown
HY-178413S	D-Mannitol-d4		/	Unkown
HY-178783	MRS8454	Modulator	/	Unkown
HY-178938	AR Degrader-3		/	Unkown
HY-178998	5-HT7R antagonist 5	Antagonist	/	Unkown
HY-179050	Androgen receptor-IN-7		/	Unkown
HY-179051	PSMA ligand 3	Ligand	/	Unkown
HY-179056	Psa-AR		/	Unkown
HY-179123	ZC9		/	Unkown
HY-179124	Apoptosis inducer 52		/	Unkown
HY-179248	Adenosine receptor antagonist 7		/	Unkown
HY-179274	β2AR agonist 5	Agonist	/	Unkown
HY-179277	MIPS3526	Agonist	/	Unkown
HY-179367	AR-102 free acid		/	Unkown
HY-179442	AR ligand-48		/	Unkown
HY-179605	AR ligand-49	Ligand	/	Unkown
HY-179671	A3AR antagonist 6	Antagonist	/	Unkown
HY-179681	A2A/A3 agonist-1	Agonist	/	Unkown
HY-179713	D2R/D3R/5-HT1AR agonist 1	Agonist	/	Unkown
HY-180409	YM580	Antagonist	/	Unkown
HY-180410	YM-1758735	Antagonist	/	Unkown
HY-180423	IRFI-165	Antagonist	98.0%	Unkown
HY-180553	NSD2-IN-6	Inhibitor	/	Unkown
HY-181427	UT-143	Antagonist	/	Unkown
HY-181727	AR/AR-V7 degrader-1		/	Unkown
HY-181877	IHCH-3185		/	Unkown
HY-181970	XY25026	Inhibitor	/	Unkown
HY-181971	XY25028	Inhibitor	/	Unkown
HY-181977	RPI-GLYT2-82	Inhibitor	/	Unkown
HY-182331	WCF-598		/	Unkown
HY-182432	A3AR antagonist-7	Antagonist	/	Unkown
HY-182687	MRS7469	Agonist	/	Unkown
HY-182714	N 0840	Antagonist	/	Unkown
HY-182722	UT-105	Degrader	/	Unkown
HY-182782	Analgesic agent-4	Ligand	/	Unkown
HY-182783	JNJ-10450232	Agonist	/	Unkown
HY-182809	Androgen receptor degrader-6		/	Unkown
HY-183239	A2AR/A2BR antagonist 2	Antagonist	/	Unkown
HY-183287	Androgen receptor antagonist-14	Antagonist	/	Unkown
HY-183357	GABAAR/5-HT2AR modulator-1		/	Unkown
HY-183414	C5aR antagonist-1	Antagonist	/	Unkown
HY-183710	CDK9-IN-50		/	Unkown
HY-183993	A3AR antagonist-8	Antagonist	/	Unkown
HY-184116	A2AR/EGFR-IN-1		/	Unkown
HY-184195	PROTAC AR Degrader-13		/	Unkown
HY-184957	Androgen receptor antagonist 15	Antagonist	/	Unkown
HY-185003	α1A-AR ligand-1	Ligand	/	Unkown
HY-185786	CBP/p300-IN-25		/	Unkown
HY-19337S	Ketodarolutamide-d3	Antagonist	/	Unkown
HY-19337S1	Ketodarolutamide-d6	Antagonist	/	Unkown
HY-19436A	Solabegron hydrochloride	Agonist	/	Unkown
HY-19532S	ZM241385-d7	Antagonist	/	Unkown
HY-19682A	Enciprazine dihydrochloride		/	Unkown
HY-19885	AR-102	Inhibitor	/	Unkown
HY-400666	AR ligand-44		/	Unkown
HY-400666A	AR ligand-44 TFA		/	Unkown
HY-403733A	(–)-JJ-450	Antagonist	/	Unkown
HY-403733B	(+)-JJ-450		/	Unkown
HY-403733C	JJ-450	Antagonist	/	Unkown
HY-46286	TTFB	Control	99.83%	Unkown
HY-70006A	Galeterone hydrochloride		/	Unkown
HY-77833	RU 56279	Antagonist	99.68%	Unkown
HY-78542S	Deshydroxyethoxy Ticagrelor-d7		/	Unkown
HY-A0052S	(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4		/	Unkown
HY-B0846S	Dimethomorph-d8		/	Unkown
HY-B1001	Todralazine	Inhibitor	/	Unkown
HY-B1421S	Ractopamine-d6 hydrochloride		/	Unkown
HY-B1421S1	Ractopamine-d9 hydrochloride		/	Unkown
HY-B1421S3	Ractopamine-d5 hydrochloride		/	Unkown
HY-B1486AS	Oxprenolol-d7	Antagonist	98.05%	Unkown
HY-B1562C	Bopindolol fumarate		/	Unkown
HY-ER013S	Sodium carbonate, AR, 99.8%-13C-1		/	Unkown
HY-N0378AGL	D-Mannitol, M200 (GMP Like)		/	Unkown
HY-N0378BGL	D-Mannitol, M100 (GMP Like)		/	Unkown
HY-N0378S4	D-Mannitol-d2		/	Unkown
HY-N0378S5	D-Mannitol-d1		/	Unkown
HY-N0378S6	D-Mannitol-13C,d2		/	Unkown
HY-N10906	(4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one		/	Unkown
HY-N11163	(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate		/	Unkown
HY-N15686	Torulene		/	Unkown
HY-N16722	(S)-ar-Turmerol		/	Unkown
HY-N17304	10S,13aR-Antofine N-oxide	Substrate	/	Unkown
HY-N17604	(6aR,11aR)-Edunol		/	Unkown
HY-N3716	Dehydroglyasperin D	Inhibitor	/	Unkown
HY-N6703S	ar-Turmerone-d3	Inducer	/	Unkown
HY-N6883	6-Methoxytricin	Inhibitor	/	Unkown
HY-P11007	β-catenin inhibitory peptoid	Inhibitor	/	Unkown
HY-P11191	AR-23	Inhibitor	/	Unkown
HY-P1129	AR-M1896	Agonist	/	Unkown
HY-P11443	SRC2-2 peptide	Ligand	/	Unkown
HY-P11476	(Z-AR)2Rh110	Substrate	/	Unkown
HY-P11660	β-catenin-IN-10	Inhibitor	/	Unkown
HY-P1345	TLQP-21	Agonist	/	Unkown
HY-P1345B	[DArg10, DAla20] TLQP-21		/	Unkown
HY-P1345C	[DArg10, Aib20] TLQP-21	Antagonist	/	Unkown
HY-P3477	Mca-PLA-Nva-Dap(Dnp)-AR-NH2		/	Unkown
HY-P4931A	Mca-KPLGL-Dap(Dnp)-AR-NH2 TFA		/	Unkown
HY-P5010	(D-Arg8)-Inotocin	Antagonist	/	Unkown
HY-P5123	Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg	Activator	/	Unkown
HY-P5214	Vasopressin Dimer (anti-parallel) TFA	Activator	/	Unkown
HY-R01656	hsa-miR-548ar-3p mimic		/	Unkown
HY-R01656A	hsa-miR-548ar-3p agomir		/	Unkown
HY-R01657	hsa-miR-548ar-5p mimic		/	Unkown
HY-R01657A	hsa-miR-548ar-5p agomir		/	Unkown
HY-RI01656	hsa-miR-548ar-3p inhibitor		/	Unkown
HY-RI01656A	hsa-miR-548ar-3p antagomir		/	Unkown
HY-RI01657	hsa-miR-548ar-5p inhibitor		/	Unkown
HY-RI01657A	hsa-miR-548ar-5p antagomir		/	Unkown
HY-RS00883	AR Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS00885	Ar Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS00892	AREG Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS01750	C5AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS03439	Cyp19a1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W041652	5-Hydroxypentanoic acid		/	Unkown
HY-W087006	p-Hydroxyphenylacetone	Antagonist	/	Unkown
HY-W095672AS4	((2S,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol-d2		98.54%	Unkown
HY-W1003189	E3 ligase Ligand 42		/	Unkown
HY-W134312	Calcium citrate,AR,99%		/	Unkown
HY-W140282	Angiotensin II antipeptide	Inhibitor	/	Unkown
HY-W192276	(±)-Desisopropylpropranolol	Antagonist	/	Unkown
HY-W471937	α1B-AR antagonist 1	Antagonist	/	Unkown
HY-W707640	Salbutamol-d4		/	Unkown
HY-W716464	Prochloraz-d7		/	Unkown
HY-W742404	Bopindolol-d9		/	Unkown
HY-W744741	Lupeol-d3		/	Unkown
HY-W751275	Ractopamine-13C2	Agonist	/	Unkown
HY-W751276	Ractopamine-13C6	Agonist	/	Unkown
HY-W854844B	JP-2-196 hydrochloride	Degrader	/	Unkown
HY-W950003	(Rac)-Finerenone-d5		/	Unkown
HY-W957364	Pomalidomide-C2-Br		/	Unkown
HY-100543R	Zenidolol (Standard)		/	Unkown
HY-10064S1	Ticagrelor-d4	Antagonist	/	Unkown
HY-100661	Cetirizine Impurity D	Antagonist	/	Unkown
HY-10122A	(Rac)-Silodosin	Inhibitor	/	Unkown
HY-10122S	Silodosin-d4	Antagonist	/	Unkown
HY-101479S	Iclaprim-d6	Inhibitor	/	Unkown
HY-101977B	(3aR)-Selitrectinib	Inhibitor	/	Unkown
HY-10275	Atecegatran	Inhibitor	/	Unkown
HY-103163	(±)-5'-Chloro-5'-deoxy-ENBA	Agonist	/	Unkown
HY-106178D	PMX 53 monoacetate		/	Unkown
HY-106684	Ridazolol	Antagonist	/	Unkown
HY-106769B	(3aR,9aR)-Fluparoxan		/	Unkown
HY-111206	β3-AR agonist 3	Agonist	/	Unkown
HY-111273	AR244555	Antagonist	/	Unkown
HY-112006	(S)-ar-Curcumene		/	Unkown
HY-114246	ONC1-13B		/	Unkown
HY-114602	AR-C117977	Inhibitor	/	Unkown
HY-115862	Benzo[c][1,8]naphthyridin-6(5H)-one	Inhibitor	/	Unkown
HY-116065	CUMI-101	Agonist	/	Unkown
HY-116508	MK 319	Inhibitor	/	Unkown
HY-118375	Phenylbutyl isoselenocyanate	Inducer	/	Unkown
HY-118944	L-748328	Antagonist	/	Unkown
HY-12122	AR-C102222	Inhibitor	/	Unkown
HY-122053	Amidephrine hydrochloride	Inhibitor	/	Unkown
HY-122177	MK181	Inhibitor	/	Unkown
HY-124259	I-AB-MECA	Ligand	/	Unkown
HY-125602	MNI-444		/	Unkown
HY-131953	Androgen receptor-IN-3	Inhibitor	/	Unkown
HY-136702	L-97-1	Antagonist	/	Unkown
HY-13715S	(Rac)-Norepinephrine-d3 formate		/	Unkown
HY-139444	AR ligand-51	Ligand	/	Unkown
HY-14300S2	Vilanterol-d12	Agonist	/	Unkown
HY-155467	MRS7935	Modulator	/	Unkown
HY-15746S	(rac)-Dobutamine-d4 hydrochloride	Agonist	/	Unkown
HY-15746S1	(rac)-Dobutamine-d6 hydrochloride	Agonist	/	Unkown
HY-157472	ACT-1014-6470	Antagonist	/	Unkown
HY-158882	FLAC6		/	Unkown
HY-159686	Aclidinium	Agonist	/	Unkown
HY-159929	Antibiotic adjuvant 2	Inhibitor	/	Unkown
HY-159930	Antibiotic adjuvant 3	Inhibitor	/	Unkown
HY-162851	Adenosine receptor agonist 1	Agonist	/	Unkown
HY-164371	(+)-JJ-74-138	Antagonist	/	Unkown
HY-164477	FL442	Modulator	/	Unkown
HY-164621	A3AR antagonist 5	Antagonist	98.17%	Unkown
HY-166478S	O-Desmethyl carvedilol-d5	Inhibitor	/	Unkown
HY-166876S	Nicergoline impurity 18-d4		/	Unkown
HY-166887S	Tiotropium bromide impurity-d3		/	Unkown
HY-166898S	trans Nonachlor-13C10		/	Unkown
HY-166906S	cis-Nonachlor-13C10		/	Unkown
HY-168296	AR ligand-29		/	Unkown
HY-168384	M04		/	Unkown
HY-168547S	AR89-d6	Inhibitor	/	Unkown
HY-169966	Boc-CH2-O-(CH2)4-OTs		/	Unkown
HY-170784	TKL-IN-1	Inhibitor	/	Unkown
HY-172730	2,2,3,3,4,4,5,5,5-Nonafluoro-N-(2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethyl)pentanamide		/	Unkown
HY-172955	E3 ligase Ligand 65		/	Unkown
HY-175457	AR-DBD ligand-Linker Conjugate 1		/	Unkown
HY-176129	AR ligand 41	Ligand	/	Unkown
HY-176759	AR-102 isopropyl ester	Agonist	/	Unkown
HY-180455	AR ligand-50	Ligand	/	Unkown
HY-19346	AR-13324 analog mesylate		98.0%	Unkown
HY-19436S	Solabegron-d8	Agonist	/	Unkown
HY-19506	AR-709	Inhibitor	/	Unkown
HY-19682	Enciprazine		/	Unkown
HY-401056	BWA-522 intermediate-3		/	Unkown
HY-B0845R	Prochloraz (Standard)		/	Unkown
HY-B1276S	Metaproterenol-d7 hemisulfate	Agonist	/	Unkown
HY-B1421S2	Ractopamine-d3 hydrochloride	Agonist	98.30%	Unkown
HY-N0092S4	Inosine-13C3	Agonist	/	Unkown
HY-N0166S	Gramine-d2		/	Unkown
HY-N0819R	Raddeanin A (Standard)	Inducer	/	Unkown
HY-N13308	8-Hydroxy-ar-turmerone		/	Unkown
HY-N6703A	(R)-ar-Turmerone		/	Unkown
HY-P10639A	C5aR2 agonist P32 acetate	Agonist	/	Unkown
HY-RS17019	Areg Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS18377	C5ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS19897	Fdxr Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24857	C5ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS26398	Fdxr Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS28019	C3ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W069173	2-Thioadenosine	Ligand	96.73%	Unkown
HY-W093399S	Ammonium bicarbonate-15N	Inhibitor	/	Unkown
HY-W130878	4-Octylphenol	Activator	/	Unkown
HY-W353622	2,5-Dioxopyrrolidin-1-yl 4-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)butanoate		/	Unkown
HY-W654262	10α-Methoxy-9,10-dihydrolysergol-d3		/	Unkown
HY-W702056	DMTr-Biotin-C6-CE phosphoramidite		/	Unkown
HY-W728110	5-MeO-pyr-T	Agonist	/	Unkown
HY-W741999	Metaproterenol-d7-1 hemisulfate	Agonist	/	Unkown
HY-W743954	Nicergoline impurity 11-d3		/	Unkown
HY-U00391	β3-AR agonist 2	Agonist	/	Unkown

Inhibitory Antibodies (7)

Cat. No.	Nom du produit	Effect	Pureté	Rare Diseases
HY-P991748	Anti-Human/Mouse Amphiregulin Antibody (AR37)	Inhibitor	99.544%	Unkown
HY-P990188	Anti-Mouse MHC class II (I-A) Antibody (Y-3P)		98.852%	Unkown
HY-P990324	Anti-AA2AR/Adenosine A2aR Antibody (3F6-9G5)	Inhibitor	≥99.0%	Unkown
HY-P991485	Anti-CD88/C5AR1 Antibody (G2_anti-C5aR)	Inhibitor	/	Unkown
HY-P990186	Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2)		/	Unkown
HY-P991318	AR20.5	Inhibitor	/	Unkown
HY-P991796	Anti-Mouse C5aR Antibody (20/70)	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Rattus norvegicus	AR	RGD	RGD:2147
Mus musculus	AR	MGD	MGI:88064
Canis familiaris	AR	VGNC	VGNC:38023
Felis catus	AR	VGNC	VGNC:67988
Macaca mulatta	AR	VGNC	VGNC:103789
Bos taurus	AR	VGNC	VGNC:26053
Others	AR	NCBI